{
  "meta": {
    "title": "00037_Late_Night_Pyq_Pyt_Marathon_-_37",
    "url": "https://brainandscalpel.vercel.app/00037-late-night-pyq-pyt-marathon-37-107cea78.html",
    "scrapedAt": "2025-11-29T17:24:47.768Z"
  },
  "questions": [
    {
      "id": 519,
      "choices": [
        {
          "id": 2072,
          "text": "<p><span style=\"color:black;font-size:12pt;\">A-delta</span></p>"
        },
        {
          "id": 2073,
          "text": "<p><span style=\"color:black;font-size:12pt;\">A- gamma</span></p>"
        },
        {
          "id": 2074,
          "text": "<p><span style=\"color:black;font-size:12pt;\">A- beta</span></p>"
        },
        {
          "id": 2075,
          "text": "<p><span style=\"color:black;font-size:12pt;\">C fibres</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Nerve fibre least susceptible to local anaesthetic is? (</span>AIIMS Nov 2017)</p>",
      "unique_key": "Q8576884",
      "question_audio": null,
      "question_video": null,
      "map_id": 13056685,
      "difficulty_level": "beginner",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D. C fibres</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The nerve fibre least susceptible to local anaesthetic is type C. Local anaesthetics work by blocking sodium channels, which prevents the initiation and propagation of action potentials in nerves. The effectiveness of local anaesthetics depends on the diameter and myelination of the nerve fibres.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Type C fibres are unmyelinated and have the smallest diameter, making them the least susceptible to local anaesthetics. This means they require a higher concentration of the anaesthetic to achieve the same level of blockade as larger, myelinated fibres.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The order of susceptibility of nerve fibres to local anaesthetics is:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>B &gt; A-d &gt; A-g &gt; A-b &gt; A-a &gt; C</strong></span></p><p>&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"color:black;font-size:12pt;\">Nerve fibres most susceptible to local anesthetic: <strong>B fibres</strong></span></p></li><li><p style=\"text-align:justify;\"><span style=\"color:black;font-size:12pt;\">Nerve fibres most resistant to local anesthetic: <strong>C fibres</strong></span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. A-delta:</strong> These are myelinated fibres with a small diameter, making them more susceptible to local anaesthetics compared to C fibres but less susceptible than larger, myelinated fibres like A-beta and A-alpha.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. A-gamma:</strong> These are myelinated fibres with a moderate diameter, making them more susceptible to local anaesthetics compared to A-delta fibres but less susceptible than A-beta and A-alpha fibres.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. A-beta:</strong> These are myelinated fibres with a larger diameter, making them more susceptible to local anaesthetics compared to A-delta and A-gamma fibres.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective :</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Type C nerve fibres are the least susceptible to local anaesthetics due to their small diameter and lack of myelination.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Ref: Miller’s Anesthesia, 9<sup>th</sup> Ed. Pgs</strong></span><span style=\"font-size:12.0pt;\"><strong> 1416-1417</strong></span></p>",
      "correct_choice_id": 2075,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20588,
      "choices": [
        {
          "id": 82315,
          "text": "<p><span style=\"font-size:12.0pt;\">Penicillin G</span></p>"
        },
        {
          "id": 82316,
          "text": "<p><span style=\"font-size:12.0pt;\">Erythromycin</span></p>"
        },
        {
          "id": 82317,
          "text": "<p><span style=\"font-size:12.0pt;\">Azithromycin</span></p>"
        },
        {
          "id": 82318,
          "text": "<p><span style=\"font-size:12.0pt;\">Cefazolin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is the drug of choice for preoperative antibiotic prophylaxis in a patient undergoing cardiac surgery?&nbsp;(NEET PG 2023)</span></p>",
      "unique_key": "Q4992797",
      "question_audio": null,
      "question_video": null,
      "map_id": 13056686,
      "difficulty_level": "beginner",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Cefazolin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The drug of choice for preoperative antibiotic prophylaxis in a patient undergoing cardiac surgery is Cefazolin, a first-generation cephalosporin. This class of antibiotics is preferred due to their efficacy against the most frequently encountered pathogenic organisms causing surgical site infections in cardiac surgeries.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Antimicrobial prophylaxis:</strong> Administered to cover the most frequently encountered pathogenic organisms causing surgical site infections.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Timing:</strong> The first dose should be given within 60 minutes before skin incision for an optimal duration of 24 hours but should not exceed 48 hours.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Special cases:</strong> In MRSA-positive cases, Vancomycin is indicated.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Penicillin G:&nbsp;</strong>Not typically used for preoperative antibiotic prophylaxis in cardiac surgery as it does not cover the range of organisms most commonly associated with surgical site infections in this context.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B</strong>.&nbsp;<strong>Erythromycin</strong>: Not the preferred choice for surgical prophylaxis in cardiac surgery due to its spectrum of activity and potential side effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C</strong>.&nbsp;<strong>Azithromycin:&nbsp;</strong>While it has a broad spectrum of activity, it is not the standard choice for preoperative prophylaxis in cardiac surgery.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The drug of choice for preoperative antibiotic prophylaxis in cardiac surgery is Cefazolin, administered within 60 minutes before incision to prevent surgical site infections.</span></p>",
      "correct_choice_id": 82318,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54678,
      "choices": [
        {
          "id": 218177,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">LMA Fastrach</span></span></span></p>"
        },
        {
          "id": 218178,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">LMA Flexible</span></span></span></p>"
        },
        {
          "id": 218179,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">LMA Proseal</span></span></span></p>"
        },
        {
          "id": 218180,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">AMBU LMA</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Identify the 2nd generation supraglottic airway device from the options given below. (INICET MAY 2024)</span></span></span></p>",
      "unique_key": "Q3173135",
      "question_audio": null,
      "question_video": null,
      "map_id": 13056687,
      "difficulty_level": "beginner",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) LMA Proseal</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The LMA Proseal is a second-generation supraglottic airway device. Second-generation devices are designed to be safer than first-generation devices, offering a higher pressure pharyngeal seal and a reduced risk of aspiration. These devices often have two tubes: one for ventilation (airway tube) and another for draining gastric secretions (gastric tube). The LMA Proseal, specifically, features these characteristics, making it a second-generation device.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/24/screenshot-2024-08-24-105259.png\" style=\"height:417px; width:400px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. LMA Fastrach:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> LMA Fastrach, also known as the intubating LMA, is not categorized as either a first or second-generation device. It is classified as a special LMA due to its unique design, which facilitates difficult intubations.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/26/010.jpg\" style=\"height:476px; width:500px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. LMA Flexible:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> The LMA Flexible is a variant of the LMA Classic, which is a first-generation device. It has a flexible airway tube but lacks the features of second-generation devices, such as a high-pressure pharyngeal seal and an additional tube for gastric drainage.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/24/screenshot-2024-08-24-105323.png\" style=\"height:283px; width:400px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Ambu LMA:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> The Ambu LMA does not have the dual-tube system that characterizes second-generation devices.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/24/screenshot-2024-08-24-105328.png\" style=\"height:210px; width:400px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">LMA Proseal is a second-generation supraglottic airway device, identified by its two-tube system that enhances safety by reducing the risk of aspiration</span></span></span></p>",
      "correct_choice_id": 218179,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "InstrumentsBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 923,
      "choices": [
        {
          "id": 3688,
          "text": "<p><span style=\"font-size:11.0pt;\">Re-intubate</span></p>"
        },
        {
          "id": 3689,
          "text": "<p><span style=\"font-size:11.0pt;\">Oxygenate and re-intubate</span></p>"
        },
        {
          "id": 3690,
          "text": "<p><span style=\"font-size:11.0pt;\">Start CPR</span></p>"
        },
        {
          "id": 3691,
          "text": "<p><span style=\"font-size:12pt;\">Watch for spontaneous breaths and re-intubate if needed</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A patient who was on a ventilator for one week suddenly gets agitated and self-extubates himself. What is the next step of management? (</span>AIIMS May 2017)</p>",
      "unique_key": "Q2217134",
      "question_audio": null,
      "question_video": null,
      "map_id": 13056688,
      "difficulty_level": "beginner",
      "subjects_id": [
        19
      ],
      "solution": "<h3><span style=\"color:#434343;font-size:16px;\"><strong>Ans. D) Watch for spontaneous breaths and re-intubate if needed</strong></span></h3><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">This is the most logical and safest immediate action. By observing the patient's spontaneous breathing, clinicians can gauge whether the patient is in distress or if they're maintaining their airway and oxygenating adequately. Self-extubation doesn't automatically necessitate re-intubation. If the patient is breathing well and does not desaturate, self-extubated patients may not require re-intubation. This can be confirmed by doing an arterial blood gas of the patient and checking his PaO2/FiO2 ratio and also watching for spontaneous breathing.</span></li></ul><h3>&nbsp;</h3><p><span style=\"color:#434343;font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Re-intubate:</strong> Simply re-intubating without assessment can be a precipitous action. It might be unnecessary if the patient can maintain their airway and oxygenation without assistance. Additionally, re-intubation has its own set of risks, including injury to the airway, so it's not a decision to be taken lightly.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Oxygenate and re-intubate:</strong> While it's always important to ensure a patient is well-oxygenated, especially if there's potential for re-intubation, the decision to re-intubate should be based on the patient's clinical status and not solely on the fact that they've self-extubated.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Start CPR:</strong> Cardiopulmonary resuscitation (CPR) is initiated in situations of cardiac arrest. There's no indication in the scenario that the patient's heart has stopped. Starting CPR without evidence of cardiac arrest can cause harm, including broken ribs and internal injury.</span></p><p>&nbsp;</p><p><span style=\"color:#434343;font-size:16px;\"><strong>Educational Objective :</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">Self-extubation requires careful assessment to determine if re-intubation is necessary. Observing the patient's spontaneous breathing and oxygenation status is crucial before making the decision to re-intubate.</span></li></ul>",
      "correct_choice_id": 3691,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4536,
      "choices": [
        {
          "id": 18120,
          "text": "<p><span style=\"font-size:12.0pt;\">Ulnar nerve</span></p>"
        },
        {
          "id": 18121,
          "text": "<p><span style=\"font-size:12.0pt;\">Median nerve</span></p>"
        },
        {
          "id": 18122,
          "text": "<p><span style=\"font-size:12.0pt;\">Radial nerve</span></p>"
        },
        {
          "id": 18123,
          "text": "<p><span style=\"font-size:12.0pt;\">Metacarpal nerve</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">The image given below shows neuromuscular monitoring of the patient after anesthesia. What is the most commonly used nerve for monitoring? (NEET PG 2022)</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/1_xhXQIou.jpg\" alt=\"\" width=\"300\" height=\"167\"></span></p>",
      "unique_key": "Q6152484",
      "question_audio": null,
      "question_video": null,
      "map_id": 13056689,
      "difficulty_level": "beginner",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Ulnar nerve</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">To monitor adequacy of neuromuscular blockade ulnar nerve is preferred.</span></li><li><span style=\"font-size:12.0pt;\">It is monitored using a <strong>Train of Four monitor/peripheral nerve stimulator</strong>.</span></li><li><span style=\"font-size:12.0pt;\">Twitching of the adductor pollicis muscle is seen on electrical stimulation of the ulnar nerve.</span></li><li><span style=\"font-size:12.0pt;\">The ulnar nerve is frequently used for monitoring neuromuscular blockade during and after anesthesia.</span></li><li><span style=\"font-size:12.0pt;\">It is typically monitored using a device known as a Train of Four (TOF) monitor or peripheral nerve stimulator.</span></li><li><span style=\"font-size:12.0pt;\">The ulnar nerve is accessible and provides a reliable location for monitoring. Twitching of the adductor pollicis muscle (a muscle in the thumb) is commonly observed when electrical stimulation is applied to the ulnar nerve.</span></li><li><span style=\"font-size:12.0pt;\">This twitch response is used to assess the degree of neuromuscular blockade and the patient's recovery from anesthesia.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Median nerve</strong>: While the median nerve can be used for neuromuscular monitoring, the ulnar nerve is more commonly preferred because of its accessibility and ease of stimulation. The adductor pollicis muscle twitch response is typically more reliable for assessing neuromuscular blockade compared to other muscles.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Radial nerve:</strong> The radial nerve can also be used for neuromuscular monitoring, but it is not as commonly chosen as the ulnar nerve. Similar to the median nerve, the ulnar nerve offers a more reliable and standard location for monitoring.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Metacarpal nerve</strong>: There is no specific nerve called the \"metacarpal nerve\" commonly used for neuromuscular monitoring.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The ulnar nerve is the most commonly used nerve for monitoring neuromuscular blockade, typically assessed using a Train of Four (TOF) monitor or peripheral nerve stimulator.</span></li></ul>",
      "correct_choice_id": 18120,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased",
        "InvestigationBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59563,
      "choices": [
        {
          "id": 237565,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">10:1</span></span></span></p>"
        },
        {
          "id": 237566,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">15:1</span></span></span></p>"
        },
        {
          "id": 237567,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">30:1</span></span></span></p>"
        },
        {
          "id": 237568,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">30:2</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">What is the correct ratio of chest compressions to breaths when a lone rescuer is performing cardiopulmonary resuscitation (CPR)?<strong> </strong>(AIIMS NOV 2016)</span></span></span></p>",
      "unique_key": "Q3715491",
      "question_audio": null,
      "question_video": null,
      "map_id": 13056690,
      "difficulty_level": "beginner",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Correct Answer</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: <strong>D. 30:2</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">According to the American Heart Association (AHA) 2015 guidelines, the recommended ratio of chest compressions to rescue breaths during CPR for all adults, whether performed by a single rescuer or two rescuers, is 30:2. This means the rescuer should deliver 30 chest compressions followed by 2 rescue breaths. This ratio ensures adequate circulation and oxygenation during resuscitation efforts.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Option A. 10:1</strong>: This ratio is not recommended for any age group or CPR scenario.</span></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Option B. 15:1</strong>: This ratio is incorrect; however, a 15:2 ratio is used in some pediatric cases with two rescuers.</span></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Option C. 30:1</strong>: This ratio is incorrect; the correct ratio is 30:2.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">When performing CPR, the correct ratio of chest compressions to breaths for a lone rescuer is 30:2, ensuring effective circulation and oxygenation</span></span></span></p>",
      "correct_choice_id": 237568,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23164,
      "choices": [
        {
          "id": 92619,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Malignant hyperthermia </span></span></span></p>"
        },
        {
          "id": 92620,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bronchospasm&nbsp;</span></span></p>\r\n\r\n<div>\r\n<div>\r\n<div class=\"msocomtxt\" id=\"_com_1\">&nbsp;</div>\r\n</div>\r\n</div>"
        },
        {
          "id": 92621,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Rebreathing </span></span></span></p>"
        },
        {
          "id": 92622,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Accidental extubation</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What condition can lead to the characteristic waveform on capnography displayed by a patient under general anesthesia as observed on the ET CO2 monitor? (</span></span>INICET May 2023)</p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/14/20-24-monitoring-in-anesthesia-6.jpg\" style=\"height:163px; width:500px\" /></span></span></span></p>",
      "unique_key": "Q9548027",
      "question_audio": null,
      "question_video": null,
      "map_id": 13056691,
      "difficulty_level": "beginner",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Bronchospasm</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>&nbsp;</strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Shark Fin appearance seen in bronchospasm due to anaphylaxis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A.</span></strong> <strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Malignant hyperthermia: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/14/20-24-monitoring-in-anesthesia-3.jpg\" style=\"height:138px; width:500px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Rebreathing:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/14/20-24-monitoring-in-anesthesia-9.jpg\" style=\"height:197px; width:500px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Accidental extubation</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/14/20-24-monitoring-in-anesthesia-7.jpg\" style=\"height:172px; width:500px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Shark Fin appearance seen in bronchospasm is due to anaphylaxis.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 92620,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 946,
      "choices": [
        {
          "id": 3780,
          "text": "<p><span style=\"font-size:12.0pt;\">Sympathetic overactivity</span></p>"
        },
        {
          "id": 3781,
          "text": "<p><span style=\"font-size:12.0pt;\">Vagal stimulation</span></p>"
        },
        {
          "id": 3782,
          "text": "<p><span style=\"font-size:12.0pt;\">Venous air embolism</span></p>"
        },
        {
          "id": 3783,
          "text": "<p><span style=\"font-size:12.0pt;\">Carotid body stimulation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A patient is undergoing modified radical neck dissection (MRND) for laryngeal malignancy. While ligating the internal jugular vein, his ETCO2 dropped from 40 mmHg to 14 mmHg, and the patient developed hypotension along with cardiac arrhythmia. Which of the following is the most likely cause? (</span>AIIMS May 2018)</p>",
      "unique_key": "Q3392744",
      "question_audio": null,
      "question_video": null,
      "map_id": 13056692,
      "difficulty_level": "beginner",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"color:#434343;font-size:12.0pt;\"><strong>Ans. C) Venous air embolism</strong></span></p><p>&nbsp;</p><p><span style=\"color:#434343;font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Venous Air Embolism:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Definition:&nbsp;</strong>It refers to the entry of air into the venous system, which can then travel to the heart and block the pulmonary circulation.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Presentation:&nbsp;</strong>A sudden drop in ETCO2, hypotension, and potential cardiac arrhythmias. A \"mill wheel\" murmur might be heard on auscultation.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Relevance to the Scenario:&nbsp;</strong>The sudden drop in ETCO2, combined with hypotension and cardiac arrhythmia following manipulation of the internal jugular vein during surgery in a head-up position, strongly suggests venous air embolism.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>There are four important events here:</strong></span></p><ol><li><span style=\"font-size:12.0pt;\">Bleeding from the internal jugular vein (severed vein which can entrap air)</span></li><li><span style=\"font-size:12.0pt;\">A drastic fall in ETCO2</span></li><li><span style=\"font-size:12.0pt;\">Hypotension</span></li><li><span style=\"font-size:12.0pt;\">Neck surgery – requires head-up position which reduces blood pressure in neck veins</span></li></ol><p>&nbsp;</p><p><span style=\"color:#434343;font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Sympathetic Overactivity:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\"><strong>Definition:&nbsp;</strong>It refers to excessive stimulation of the sympathetic nervous system.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Presentation:&nbsp;</strong>It typically manifests as hypertension (raised blood pressure) and tachycardia (increased heart rate).</span></li><li><span style=\"font-size:12.0pt;\"><strong>Relevance to the Scenario:&nbsp;</strong>The patient developed hypotension, not hypertension, so this option is less likely.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Vagal Stimulation:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\"><strong>Definition:&nbsp;</strong>Activation of the vagus nerve, one of the cranial nerves, which plays a role in controlling the heart, lungs, and digestive tract.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Presentation:&nbsp;</strong>Vagal stimulation can cause bradycardia (slowed heart rate) and hypotension.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Relevance to the Scenario:&nbsp;</strong>While vagal stimulation can explain the hypotension and arrhythmia, it does not account for the drastic drop in ETCO2.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Carotid Body Stimulation:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\"><strong>Definition:&nbsp;</strong>The carotid body is a small cluster of chemoreceptors located at the bifurcation of the carotid artery. It monitors changes in blood oxygen levels.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Presentation:&nbsp;</strong>Stimulation can cause changes in heart rate and blood pressure, but it typically results in hypertension.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Relevance to the Scenario:&nbsp;</strong>Given that the patient is hypotensive, this option is less likely.</span></li></ul><p>&nbsp;</p><p><span style=\"color:#434343;font-size:12.0pt;\"><strong>Educational Objective :</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">A sudden drop in ETCO2, hypotension, and cardiac arrhythmias during surgery, especially involving the internal jugular vein and head-up positioning, strongly suggests venous air embolism.</span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Ref: Miller’s Anesthesia, 9<sup>th</sup> Ed. Pgs 1878-1880</strong></span></p>",
      "correct_choice_id": 3782,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43255,
      "choices": [
        {
          "id": 172687,
          "text": "<p><span style=\"font-size:12pt;\">PPV with ETT</span></p>"
        },
        {
          "id": 172688,
          "text": "<p><span style=\"font-size:12pt;\">Bag and mask ventilation</span></p>"
        },
        {
          "id": 172689,
          "text": "<p><span style=\"font-size:12pt;\">Oxygen&nbsp; therapy</span></p>"
        },
        {
          "id": 172690,
          "text": "<p><span style=\"font-size:12pt;\">Intubation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A child presents with acute respiratory distress. On examination, the abdomen was scaphoid. Which of the&nbsp; following should not be performed in this patient : (INICET NOVEMBER 2023)</span></p>",
      "unique_key": "Q5866097",
      "question_audio": null,
      "question_video": null,
      "map_id": 13056693,
      "difficulty_level": "beginner",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B. Bag and mask ventilation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Bag and mask ventilation is typically the first step in managing respiratory distress to provide support. However, in the case of a scaphoid abdomen, which suggests the possibility of a congenital diaphragmatic hernia, this method can be dangerous. It could inflate the stomach and intestines, which may be in the thoracic cavity, thus reducing lung volume further and potentially worsening respiratory distress. Therefore, bag and mask ventilation should be avoided in this scenario.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. PPV with ETT:</strong> Although this can be cautiously used, it should be carefully monitored due to the risk of increasing thoracic pressure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Oxygen therapy:</strong> This is a safe method to improve oxygenation without the risks associated with positive pressure ventilation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Intubation:</strong> This is necessary for securing the airway and providing ventilatory support in severe respiratory distress and is safer compared to bag and mask ventilation in the context of a suspected diaphragmatic hernia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Bag and mask ventilation should be avoided in a child with acute respiratory distress and a scaphoid abdomen, as it may exacerbate the condition if a congenital diaphragmatic hernia is present.</span></p>",
      "correct_choice_id": 172688,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 1024,
      "choices": [
        {
          "id": 4092,
          "text": "<p><span style=\"font-size:12pt;\">Reducing the secretions</span></p>"
        },
        {
          "id": 4093,
          "text": "<p><span style=\"font-size:12pt;\">Sedative effect</span></p>"
        },
        {
          "id": 4094,
          "text": "<p><span style=\"font-size:12pt;\">Skeletal muscle relaxant</span></p>"
        },
        {
          "id": 4095,
          "text": "<p><span style=\"font-size:12pt;\">Anxiolytic</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Glycopyrrolate is used as a preanesthetic agent for? (</span>INICET May 2020)</p>",
      "unique_key": "Q7471152",
      "question_audio": null,
      "question_video": null,
      "map_id": 13056694,
      "difficulty_level": "beginner",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Reducing the secretions&nbsp;</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Mechanism of Action:&nbsp;</strong>Glycopyrrolate is an anticholinergic agent, which means it acts by blocking the action of acetylcholine on muscarinic receptors.</span></li><li><span style=\"font-size:12pt;\"><strong>Effect:&nbsp;</strong>One of the effects of this action is the reduction in the production of secretions, such as saliva and bronchial mucus.</span></li><li><span style=\"font-size:12pt;\"><strong>Clinical Use:&nbsp;</strong>Given before anesthesia, it can prevent excessive secretions that might interfere with the procedure or increase the risk of aspiration. Hence, this is the primary reason glycopyrrolate is used as a preanesthetic agent.</span></li></ul><p>&nbsp;</p><p><span style=\"color:#434343;font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Sedative effect:&nbsp;</strong>Glycopyrrolate does not have inherent sedative properties. While it may have some central side effects due to its anticholinergic action, its quaternary structure limits its ability to cross the blood-brain barrier. Thus, it doesn't produce sedation in the same manner as agents specifically designed for that purpose, like benzodiazepines.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Skeletal muscle relaxant:&nbsp;</strong>Glycopyrrolate does not have skeletal muscle relaxant properties.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Anxiolytic:&nbsp;</strong>Glycopyrrolate is not used as an anxiolytic.</span></p><p>&nbsp;</p><p><span style=\"color:#434343;font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Glycopyrrolate is primarily used as a preanesthetic agent to reduce secretions, thus preventing complications during anesthesia and surgery.</span></li></ul>",
      "correct_choice_id": 4092,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4484,
      "choices": [
        {
          "id": 17913,
          "text": "<p><span style=\"font-size:12pt;\">Etomidate</span></p>"
        },
        {
          "id": 17914,
          "text": "<p><span style=\"font-size:12pt;\">Propofol</span></p>"
        },
        {
          "id": 17915,
          "text": "<p><span style=\"font-size:12pt;\">Thiopentone</span></p>"
        },
        {
          "id": 17916,
          "text": "<p><span style=\"font-size:12pt;\">Ketamine</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which among the following IV anaesthetic causes least myocardial depression and maximum hemodynamic stability? (</span>NEET PG 2019)</p>",
      "unique_key": "Q3670059",
      "question_audio": null,
      "question_video": null,
      "map_id": 13056695,
      "difficulty_level": "beginner",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Etomidate</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Among the options given, Etomidate is unique in that it causes minimal cardiovascular depression.</span></li><li><span style=\"font-size:12pt;\">This makes it particularly useful in patients with compromised cardiac function or hemodynamic instability</span></li><li><span style=\"background-color:white;font-size:12pt;\"><strong>Etomidate is an imidazoline derivative used for IV anaesthesia induction, and it offers several advantages:</strong></span><ul><li><span style=\"background-color:white;font-size:12pt;\"><strong>Low risk of myocardial depression</strong></span></li><li><span style=\"background-color:white;font-size:12pt;\"><strong>Hemodynamic stability</strong> on bolus injection</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong> <strong>Propofol</strong>: Propofol can cause myocardial depression, leading to a decrease in blood pressure. It also produces vasodilation which can further lower blood pressure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong> <strong>Thiopentone</strong>: Thiopentone can cause myocardial depression, leading to a decrease in cardiac output and blood pressure. It also has a vasodilatory effect which can further compromise hemodynamics.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D</strong>. <strong>Ketamine</strong>: Unlike most other anesthetics, Ketamine typically has a stimulatory effect on the cardiovascular system. It often increases heart rate and blood pressure due to its sympathetic stimulatory effects. However, in patients with depleted catecholamines or in certain pathological conditions, it might not exhibit this stimulatory effect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Propofol and Thiopentone are known to cause myocardial depression, Etomidate is recognized for its minimal cardiovascular depression, and Ketamine typically stimulates the cardiovascular system, but with certain exceptions.</span></p>",
      "correct_choice_id": 17913,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 1033,
      "choices": [
        {
          "id": 4128,
          "text": "<p><span style=\"font-size:12.0pt;\">Lignocaine</span></p>"
        },
        {
          "id": 4129,
          "text": "<p><span style=\"font-size:12.0pt;\">Cocaine</span></p>"
        },
        {
          "id": 4130,
          "text": "<p><span style=\"font-size:12.0pt;\">Bupivacaine</span></p>"
        },
        {
          "id": 4131,
          "text": "<p><span style=\"font-size:12.0pt;\">Prilocaine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following local&nbsp; anaesthetic causes hypertension?</span>(INICET MAY 2022)</p>",
      "unique_key": "Q1578984",
      "question_audio": null,
      "question_video": null,
      "map_id": 13056696,
      "difficulty_level": "intermediate",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Cocaine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Cocaine</strong>: An ester local anesthetic that is also a powerful central nervous system stimulant. One of the well-known cardiovascular effects of cocaine is hypertension, due to its potent vasoconstrictive properties.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Lignocaine:&nbsp;</strong>is<strong>&nbsp;</strong>an amide local anesthetic that is used to produce numbness during procedures and for treating various types of pain. It can cause side effects such as dizziness and low blood pressure but is not known for causing hypertension.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Bupivacaine</strong>: An amide local anesthetic known for its potent and long-lasting numbing effect. It can cause cardiovascular complications, but like lignocaine, it is more associated with cardiac toxicity rather than hypertension.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D</strong>. <strong>Prilocaine</strong>: Another amide local anesthetic, similar to lignocaine, and not commonly associated with causing hypertension.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Cocaine is the local anesthetic known to cause hypertension due to its vasoconstrictive effects.</span></li></ul>",
      "correct_choice_id": 4129,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 1035,
      "choices": [
        {
          "id": 4136,
          "text": "<p><span style=\"color:black;font-size:12pt;\">Bronchial asthma</span></p>"
        },
        {
          "id": 4137,
          "text": "<p><span style=\"color:black;font-size:12pt;\">Renal failure</span></p>"
        },
        {
          "id": 4138,
          "text": "<p><span style=\"color:black;font-size:12pt;\">Emphysema</span></p>"
        },
        {
          "id": 4139,
          "text": "<p><span style=\"color:black;font-size:12pt;\">Acute myocardial infarction</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following is not a contraindication to the use of morphine? (</span>AIIMS Nov 2018)</p>",
      "unique_key": "Q7306994",
      "question_audio": null,
      "question_video": null,
      "map_id": 13056697,
      "difficulty_level": "intermediate",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D. Acute myocardial infarction</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Acute myocardial infarction:</strong> Morphine is often used in the setting of acute myocardial infarction (AMI) to relieve pain and anxiety. It also has the beneficial effect of reducing preload and afterload on the heart, which can decrease myocardial oxygen demand. This makes it beneficial in the management of AMI. It's not a contraindication.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Bronchial asthma:</strong> Morphine can induce histamine release, which may lead to bronchospasm. In patients with bronchial asthma, this bronchospasm can exacerbate respiratory difficulties, making morphine potentially dangerous for these patients.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Renal failure:</strong> Morphine is metabolized in the liver and its metabolites, especially morphine-6-glucuronide, are excreted by the kidneys. In the case of renal failure, these active metabolites can accumulate, leading to prolonged and potentially toxic effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Emphysema:</strong> Morphine has a depressive effect on the respiratory center in the brain, leading to respiratory depression. In patients with emphysema, a condition already characterized by compromised respiratory function, morphine can exacerbate respiratory difficulties and decrease the drive to breathe.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective :</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Morphine is beneficial and not contraindicated in the management of acute myocardial infarction (AMI) as it helps to relieve pain, reduce anxiety, and decrease myocardial oxygen demand.</span></p>",
      "correct_choice_id": 4139,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 897,
      "choices": [
        {
          "id": 3584,
          "text": "<p style=\"text-align:justify;\"><span style=\"color:black;font-size:12.0pt;\">1,3,4,5</span></p>"
        },
        {
          "id": 3585,
          "text": "<p style=\"text-align:justify;\"><span style=\"color:black;font-size:12.0pt;\">2,3,4,5</span></p>"
        },
        {
          "id": 3586,
          "text": "<p style=\"text-align:justify;\"><span style=\"color:black;font-size:12.0pt;\">2,4</span></p>"
        },
        {
          "id": 3587,
          "text": "<p style=\"text-align:justify;\"><span style=\"color:black;font-size:12.0pt;\">1,4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following equipment is required for putting intravenous cannula in a newborn?</span>(INICET NOV 2022)</p><p>&nbsp;</p><ol><li><p style=\"text-align:justify;\"><span style=\"color:black;font-size:12.0pt;\">22G cannula</span></p></li><li><p style=\"text-align:justify;\"><span style=\"color:black;font-size:12.0pt;\">24G IV cannula</span></p></li><li><p style=\"text-align:justify;\"><span style=\"color:black;font-size:12.0pt;\">5-mL syringe</span></p></li><li><p style=\"text-align:justify;\"><span style=\"color:black;font-size:12.0pt;\">Adhesive tape</span></p></li><li><p style=\"text-align:justify;\"><span style=\"color:black;font-size:12.0pt;\">Normal saline</span></p></li></ol>",
      "unique_key": "Q1241863",
      "question_audio": null,
      "question_video": null,
      "map_id": 13056698,
      "difficulty_level": "beginner",
      "subjects_id": [
        19
      ],
      "solution": "<p style=\"margin-left:1px;\"><span style=\"font-size:12.0pt;\"><strong>Ans. B. 2,3,4,5</strong></span></p><p style=\"margin-left:1px;\">&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>2. 24G IV cannula:</strong> This refers to a 24-gauge (24G) cannula, which is typically used for neonates and infants due to its smaller diameter, making it suitable for their small and fragile veins.</span></p><p><span style=\"font-size:12pt;\"><strong>3. 5-mL syringe:</strong> While placing an IV cannula, it's essential to have a syringe attached. The syringe helps to test the patency of the cannula once it's in the vein (flashback of blood can be seen), and it also assists in gently flushing the cannula with normal saline to ensure it's correctly positioned.</span></p><p><span style=\"font-size:12pt;\"><strong>4. Adhesive tape:</strong> Once the cannula is in position, adhesive tape or a securement device is necessary to stabilize and fix the cannula in place, preventing it from dislodging.</span></p><p><span style=\"font-size:12pt;\"><strong>5. Normal saline:</strong> Normal saline is used for flushing the cannula once it's in place to ensure patency. It's also utilized to keep the cannula patent if it's not immediately hooked up to an IV line.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>1. 22G IV cannula:</strong> A 22-gauge (22G) cannula is larger and may be used for older infants or children but is often too large for a newborn's tiny veins. Hence, it is not typically used for neonates.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective :</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">For placing an IV cannula in a newborn, the equipment required includes a 24G needle, a 5-mL syringe, adhesive tape, and normal saline.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/06/screenshot-2024-07-06-160732.png\" alt=\"\" width=\"450\" height=\"300\"></p>",
      "correct_choice_id": 3585,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "INICET",
        "InstrumentsBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59566,
      "choices": [
        {
          "id": 237577,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Mapleson F</span></span></span></p>"
        },
        {
          "id": 237578,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Mapleson E</span></span></span></p>"
        },
        {
          "id": 237579,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Mapleson A</span></span></span></p>"
        },
        {
          "id": 237580,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mapleson C</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 60-year-old man is undergoing a minor surgical procedure under sedation with spontaneous ventilation. The anesthesiologist needs to select the most appropriate breathing circuit to ensure efficient gas exchange and minimal work of breathing. The goal is to maintain spontaneous respiration with optimal support throughout the procedure. Which of the following anesthesia circuits is most effective for spontaneous breathing in adults?</span></span></span></p>",
      "unique_key": "Q2615248",
      "question_audio": null,
      "question_video": null,
      "map_id": 13056699,
      "difficulty_level": "beginner",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Correct Answer: </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">C. Mapleson A</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Mapleson A, also known as Magill&rsquo;s circuit, is the most effective anesthesia breathing circuit for spontaneous breathing in adults. It is designed to minimize the work of breathing and efficiently eliminate carbon dioxide during spontaneous respiration. In the Mapleson classification, the circuits are tailored for specific purposes: Mapleson A is optimal for spontaneous breathing because the APL valve is located at the patient&rsquo;s end, facilitating efficient exhalation of expired gases and fresh gas flow, which reduces the risk of rebreathing. For controlled ventilation, Mapleson D (Bain&rsquo;s circuit) is preferred due to its distal APL valve design that supports positive pressure ventilation. Meanwhile, Mapleson F is the most effective for pediatric patients, as it provides low resistance and minimal dead space suitable for smaller tidal volumes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Mapleson F</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Mapleson F, or Jackson Rees&rsquo; modification, is primarily used in pediatric anesthesia due to its low resistance and minimal dead space. It is less suitable for adults because it does not adequately prevent rebreathing with larger tidal volumes, making it less effective for spontaneous breathing in this patient population.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">B. Mapleson E</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Mapleson E is a non-rebreathing circuit without a reservoir bag or APL valve, primarily used in pediatric patients. It lacks the necessary control over airway pressures, making it inefficient for spontaneous breathing in adults.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">D. Mapleson C</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Mapleson C has a similar setup to Mapleson A but lacks the corrugation in its breathing tube, resulting in increased resistance and less effective carbon dioxide elimination. This design makes it less suitable for spontaneous breathing compared to Mapleson A.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">For adults, Mapleson A (Magill&rsquo;s circuit) is the most effective circuit for spontaneous breathing, while Mapleson D (Bain&rsquo;s circuit) is best for controlled ventilation. For pediatric patients, Mapleson F provides optimal performance due to its low resistance and minimal dead space. Understanding the specific applications of these circuits ensures proper ventilation support tailored to the patient&#39;s needs.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/01/picture4.jpg\" style=\"height:581px; width:700px\" /></span></span></span></p>",
      "correct_choice_id": 237579,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4523,
      "choices": [
        {
          "id": 18068,
          "text": "<p><span style=\"font-size:12.0pt;\">X-ray chest</span></p>"
        },
        {
          "id": 18069,
          "text": "<p><span style=\"font-size:12.0pt;\">Auscultation</span></p>"
        },
        {
          "id": 18070,
          "text": "<p><span style=\"font-size:12.0pt;\">End-tidal CO2 concentration</span></p>"
        },
        {
          "id": 18071,
          "text": "<p><span style=\"font-size:12.0pt;\">Chest rise</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 30-year-old male patient was intubated for surgery by a final-year resident. Which of the following is the best method to confirm the position of the endotracheal tube? (NEET PG 2021)</span></p>",
      "unique_key": "Q3682189",
      "question_audio": null,
      "question_video": null,
      "map_id": 13056821,
      "difficulty_level": "beginner",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C) End-tidal CO2 concentration</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Methods to confirm endotracheal intubation:</strong></span></p><ul><li><span style=\"font-size:16px;\">X-ray chest</span></li><li><span style=\"font-size:16px;\">Auscultation</span></li><li><span style=\"font-size:16px;\">End-tidal CO2 concentration</span></li><li><span style=\"font-size:16px;\">Chest rise</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\">This is considered the best method to confirm ETT placement in real-time. Capnography measures the concentration of carbon dioxide (CO2) in the exhaled breath. When the ETT is correctly placed in the trachea, it will produce a waveform with a consistent and relatively high end-tidal CO2 concentration. In contrast, if the ETT is in the esophagus or there is an airway obstruction, the end-tidal CO2 concentration will be lower or absent, providing immediate feedback to the anesthesiologist.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. X-ray chest</strong>: While a chest X-ray can confirm the placement of the ETT, it is not a practical or immediate method for confirming tube placement during intubation. X-rays are typically used for confirmation after intubation.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Auscultation:</strong> Auscultation involves listening to breath sounds over the chest and epigastrium to assess tube placement. While it can be a useful method, it may not always be reliable, especially in noisy clinical environments, and it may not detect esophageal intubation or partial airway obstruction.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Chest rise</strong>: Observing chest rise can be helpful, but it is not as reliable as capnography. In some cases, chest rise may be present even if the ETT is incorrectly placed in the esophagus, especially in cases of esophageal intubation with positive-pressure ventilation.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">The gold standard for confirming ETT placement is indeed the end-tidal CO2 concentration assessed by capnography.</span></li><li><span style=\"font-size:16px;\">It provides real-time feedback and is considered a more reliable method compared to other options, ensuring that the ETT is correctly placed in the trachea and the patient is being ventilated effectively.</span></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/12/whatsapp-image-2023-06-12-at-190121011010201021.jpg\" alt=\"\" width=\"700\" height=\"519\"></span></p>",
      "correct_choice_id": 18070,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "CriteriaBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 1027,
      "choices": [
        {
          "id": 4104,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Venturi mask</span></p>"
        },
        {
          "id": 4105,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Hudson mask</span></p>"
        },
        {
          "id": 4106,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Non-rebreathing mask</span></p>"
        },
        {
          "id": 4107,
          "text": "<p><span style=\"font-size:12pt;\">Nasal cannula</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In conventional oxygen therapy, which device will deliver the highest FiO<sub>2</sub>? (</span>INICET May 2021)</p>",
      "unique_key": "Q7220267",
      "question_audio": null,
      "question_video": null,
      "map_id": 13056822,
      "difficulty_level": "beginner",
      "subjects_id": [
        19
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. C) Non</strong>-<strong>rebreathing mask</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>FiO2 Delivery:</strong> A non-rebreathing mask can deliver an FiO2 of up to 80% at flow rates of 10-15 L/min. This mask has a reservoir bag that fills with oxygen and a one-way valve that prevents the exhaled air from entering the reservoir bag, ensuring a higher concentration of oxygen is inhaled.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Venturi mask: </strong>The Venturi mask delivers a precise FiO2, which can range from 24% to 66%, depending on the entrainment device used. It is often used in patients who require a specific oxygen concentration.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Hudson mask: </strong>This option appears to refer to a simple face mask, which can deliver up to 60% FiO2 at 10 L/min. It is less efficient in delivering high concentrations of oxygen compared to a non-rebreathing mask.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Nasal cannula: </strong>A nasal cannula typically delivers up to 44% FiO2 at a flow rate of 6 L/min. It is comfortable and used for patients who need low to moderate oxygen supplementation but cannot deliver the high concentrations achievable with a non-rebreathing mask.</span></p><h3>&nbsp;</h3><h3><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></h3><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The non-rebreathing mask delivers the highest FiO2 in conventional oxygen therapy, capable of providing up to 80% FiO2 at flow rates of 10-15 L/min, making it suitable for patients requiring high concentrations of oxygen.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/02/screenshot-2024-07-02-151423.jpg\" alt=\"\" width=\"1000\" height=\"616\"></span></p>",
      "correct_choice_id": 4106,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "INICET",
        "InstrumentsBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 999,
      "choices": [
        {
          "id": 3992,
          "text": "<p><span style=\"font-size:12.0pt;\">Decreases need of intubation</span></p>"
        },
        {
          "id": 3993,
          "text": "<p><span style=\"font-size:12.0pt;\">Reduces nasopharyngeal dead space</span></p>"
        },
        {
          "id": 3994,
          "text": "<p><span style=\"font-size:12.0pt;\">Heating and humidification</span></p>"
        },
        {
          "id": 3995,
          "text": "<p><span style=\"font-size:12.0pt;\">PEEP</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which is not an obvious advantage of high-flow nasal cannula? (</span>AIIMS May 2019)</p>",
      "unique_key": "Q7872540",
      "question_audio": null,
      "question_video": null,
      "map_id": 13056823,
      "difficulty_level": "difficult",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Decreases need of intubation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/02/screenshot-2024-07-02-153015.jpg\" alt=\"\" width=\"450\" height=\"424\"></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Decreases need of intubation:</strong> While high-flow nasal cannula (HFNC) can be an intermediate step between standard oxygen therapy and more invasive respiratory support, it doesn't always eliminate the need for intubation. HFNC can improve oxygenation and reduce the work of breathing in many patients, but it may not be sufficient in cases of severe respiratory failure where intubation becomes necessary.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Reduces nasopharyngeal dead space: </strong>High-flow nasal cannula allows for the delivery of oxygen at much higher flow rates than standard nasal cannulae. This higher flow rate can flush out the nasopharyngeal dead space, leading to a more consistent fraction of inspired oxygen (FiO2) and improving alveolar ventilation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Heating and humidification: </strong>One of the distinct features of HFNC systems is that they deliver oxygen that's both heated and humidified. This enhances comfort, reduces the risk of mucosal drying and injury, and can help improve mucociliary clearance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. PEEP (Positive End-Expiratory Pressure):</strong> PEEP refers to the maintenance of a positive pressure in the airways at the end of expiration, which can prevent alveolar collapse. The high flow rate from HFNC can generate a degree of PEEP, especially with the mouth closed. This can help recruit alveoli and improve oxygenation in certain patients.</span></p><p style=\"margin-left:48px;\">&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">While high-flow nasal cannula (HFNC) offers several advantages, including reducing nasopharyngeal dead space, providing heated and humidified oxygen, and generating PEEP, it does not always eliminate the need for intubation in patients with severe respiratory failure.</span></li></ul>",
      "correct_choice_id": 3992,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "InstrumentsBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 568,
      "choices": [
        {
          "id": 2268,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Respiratory distress</span></span></p>"
        },
        {
          "id": 2269,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Post-surgical pain</span></span></p>"
        },
        {
          "id": 2270,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Postoperative nausea and vomiting</span></span></p>"
        },
        {
          "id": 2271,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bleeding</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is the most common cause for hospital admission after day care surgery? (</span></span>INICET Nov 2021)</p>",
      "unique_key": "Q9126826",
      "question_audio": null,
      "question_video": null,
      "map_id": 13056824,
      "difficulty_level": "beginner",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Postoperative nausea and vomiting </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The most common cause for hospital admission or delayed discharge from the hospital post day care surgery is Postoperative nausea and vomiting (PONV). PONV is a frequent complication following surgery and anesthesia, significantly impacting patient comfort and recovery, and often leading to extended hospital stays or readmissions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A. Respiratory distress</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While it is a serious concern, it is not as commonly the cause for hospital admission after day care surgery as PONV.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B. Post-surgical pain</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Although post-surgical pain is a common issue, it is generally managed effectively with analgesics and is less frequently the cause for hospital admission compared to PONV.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><strong><span style=\"font-family:Calibri,sans-serif\">Option</span><span style=\"font-family:Times New Roman,serif\">&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D. Bleeding:</span></strong><span style=\"font-family:Calibri,sans-serif\"> Postoperative bleeding can be a complication but is less common as a cause for hospital admission after day care surgery compared to PONV.</span></span></p>\r\n\r\n<p style=\"margin-left:14px\">&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Risk factors for PONV:</span></span></strong></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/06/screenshot-2024-07-06-115839.jpg\" style=\"height:723px; width:1000px\" /></span></span></strong></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective :</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Postoperative nausea and vomiting (PONV) is the most common cause for hospital admission or delayed discharge after day care surgery.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Miller&rsquo;s Anesthesia, 9<sup>th</sup> Ed. Pg</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> 2603</span></span></strong></p>",
      "correct_choice_id": 2270,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 1037,
      "choices": [
        {
          "id": 4144,
          "text": "<p><span style=\"font-size:12.0pt;\">Normal pH can't rule out acid base disorder</span></p>"
        },
        {
          "id": 4145,
          "text": "<p><span style=\"font-size:12.0pt;\">Add 0.5 ml Heparin to the syringe before taking blood</span></p>"
        },
        {
          "id": 4146,
          "text": "<p><span style=\"font-size:12.0pt;\">If modified Allen’s test is negative, alternate site is chosen</span></p>"
        },
        {
          "id": 4147,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Radial artery is the preferred site</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">You are an intern posted in the ICU. While taking a blood sample for ABG, which of the following steps would you not do? (</span>AIIMS Nov 2019)</p>",
      "unique_key": "Q2211713",
      "question_audio": null,
      "question_video": null,
      "map_id": 13056825,
      "difficulty_level": "intermediate",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B. Add 0.5 ml Heparin to the syringe before taking blood</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Add 0.5 ml Heparin to the syringe before taking blood:</strong> Traditionally, to prevent blood from clotting inside the syringe when obtaining an ABG, a small amount of heparin was added to the syringe. However, in contemporary practice, syringes used for ABG are pre-heparinized, which means they already contain a coating of dry heparin that will mix with the blood sample and prevent clotting. Adding additional heparin to such a syringe is unnecessary and can dilute the sample, potentially altering the results.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Normal pH can't rule out acid base disorder:</strong> This statement is accurate. A patient can have a mixed acid-base disorder where two primary disorders (e.g., metabolic acidosis and respiratory alkalosis) coexist and \"cancel\" each other out, leading to a seemingly \"normal\" pH. However, when the components of the arterial blood gas (ABG) like PaCO2 and HCO3- are evaluated, abnormalities can be detected.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. If modified Allen’s test is negative, alternate site is chosen:</strong> The modified Allen's test is a simple way to evaluate the collateral blood flow to the hand via the ulnar artery. Before taking a sample or placing an arterial line in the radial artery, it's a recommended step to ensure that if the radial artery becomes occluded, the hand will still receive adequate blood flow. If the test is negative (indicative of inadequate collateral flow), it's safer to choose an alternate site for arterial puncture.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Radial artery is the preferred site:</strong> The radial artery is commonly chosen for ABG sampling and arterial line placement due to its accessibility, the presence of collateral blood flow (via the ulnar artery), and its relatively superficial location which makes puncture technically easier. Furthermore, complications like hematoma or injury are less problematic at this location when compared to other potential sites, such as the femoral artery.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective :</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Adding extra heparin to pre-heparinized ABG syringes is unnecessary and can alter the blood sample.</span></p>",
      "correct_choice_id": 4145,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 1070,
      "choices": [
        {
          "id": 4276,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Central line insertion</span></span></span></span></p>"
        },
        {
          "id": 4277,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Arterial line insertion</span></span></span></span></p>"
        },
        {
          "id": 4278,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Airway management</span></span></span></span></p>"
        },
        {
          "id": 4279,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Cardiopulmonary resuscitation</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The given set of instruments are used in? (</span></span>INICET Nov 2020)</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/26/untitled-114.jpg\" style=\"height:224px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q3007585",
      "question_audio": null,
      "question_video": null,
      "map_id": 13056826,
      "difficulty_level": "beginner",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Airway management </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The instruments shown in the image are part of an airway cart. The equipment typically found in an airway cart is designed for managing the airway during anesthesia or in emergency situations. The contents of the airway cart usually include:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Laryngoscope:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> A device used to obtain a view of the vocal folds and the glottis, which is essential for endotracheal intubation.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tracheal tubes of various sizes:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> These tubes are used to secure the airway by passing through the trachea.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Masks:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Various types of masks to deliver oxygen or anesthetic gases.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Laryngeal mask airways (LMA):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> A device placed over the laryngeal inlet to provide ventilation.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Flexible fiberoptic intubation equipment:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Used for intubation in difficult airway situations.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Retrograde intubation equipment:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Tools used for intubation when conventional methods fail.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Front of neck access equipment:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Devices for surgical airway access.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Equipment required for emergency invasive airway access:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Tools needed for emergency tracheostomy or cricothyrotomy.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Central line insertion:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This procedure requires different instruments such as central venous catheters, guidewires, dilators, and sterile drapes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Arterial line insertion:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This involves the use of arterial catheters, guidewires, and transducers, not typically found in an airway cart.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Cardiopulmonary resuscitation (CPR):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> CPR primarily requires defibrillators, chest compression devices, and basic airway management tools like bag-valve masks (BVM), but not the comprehensive set shown for airway management.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective :</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The instruments in an airway cart are specifically designed for various procedures involved in airway management, including intubation and emergency airway access.</span></span></p>",
      "correct_choice_id": 4278,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET",
        "InstrumentsBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4497,
      "choices": [
        {
          "id": 17964,
          "text": "<p><span style=\"color:black;font-size:12pt;\">Exercise ECG testing</span></p>"
        },
        {
          "id": 17965,
          "text": "<p><span style=\"color:black;font-size:12pt;\">Dobutamine stress echocardiography</span></p>"
        },
        {
          "id": 17966,
          "text": "<p><span style=\"color:black;font-size:12pt;\">Myocardial perfusion scintigraphy</span></p>"
        },
        {
          "id": 17967,
          "text": "<p><span style=\"color:black;font-size:12pt;\">Coronary angiography</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following non-invasive investigations provides the most accurate prognostic information with respect to predicting risks of perioperative cardiac complications? (NEET PG 2020)</span></p>",
      "unique_key": "Q8106037",
      "question_audio": null,
      "question_video": null,
      "map_id": 13056827,
      "difficulty_level": "beginner",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Dobutamine stress echocardiography</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">This is an echocardiogram that is performed while the heart is under the stress of increased workload. If a patient cannot exercise, a drug called dobutamine is administered to simulate the effects of exercise on the heart.</span></li><li><span style=\"font-size:12pt;\">The test helps identify areas of the heart that may not be receiving enough blood due to blockages in the coronary arteries. A significant change in the motion of the heart wall during the test is a strong predictor of perioperative cardiac complications, making this test highly valuable in the mentioned context.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Exercise ECG testing:&nbsp;</strong>Exercise ECG testing, also known as exercise stress testing or treadmill testing, involves the patient exercising on a treadmill or stationary bicycle while their heart rate, blood pressure, and electrocardiogram (ECG) are monitored. The purpose is to determine how the heart responds to the stress of exercise. Abnormal changes in the ECG during or after exercise may suggest coronary artery disease (CAD). While this test can indicate the presence of CAD, it does not specifically predict perioperative cardiac complications.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Myocardial perfusion scintigraphy:&nbsp;</strong>Also known as a nuclear stress test, this investigation involves injecting a small amount of radioactive substance into the patient and using a special camera to visualize how blood flows through the heart muscle, both at rest and during stress (either exercise or with a medication). This test can identify areas of the heart that aren't getting enough blood, indicative of CAD. While it can detect and evaluate the severity of CAD, it's less specific than dobutamine stress echocardiography in predicting perioperative cardiac complications.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Coronary angiography:&nbsp;</strong>This is a procedure in which a contrast dye is injected into the coronary arteries, and X-rays are taken to visualize the flow of blood through these arteries. It is used to directly visualize blockages in the coronary arteries. As the \"gold standard\" for diagnosing CAD, coronary angiography can provide detailed information about the location and severity of blockages. However, it's an invasive procedure, involving threading a catheter through the blood vessels to the heart, and carries risks such as bleeding, allergic reactions, or kidney damage.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Dobutamine stress echocardiography is the most accurate non-invasive investigation for predicting perioperative cardiac complications due to its ability to simulate exercise and identify areas of the heart with reduced blood flow.</span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12pt;\"><strong>Ref: Miller’s Anesthesia, 9<sup>th</sup> Ed. Pg</strong></span><span style=\"font-size:12pt;\"> <strong>935</strong></span></p>",
      "correct_choice_id": 17965,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13784,
      "choices": [
        {
          "id": 55097,
          "text": "<p><span style=\"font-size:12.0pt;\">Mamillary body</span></p>"
        },
        {
          "id": 55098,
          "text": "<p><span style=\"font-size:12.0pt;\">Hippocampus</span></p>"
        },
        {
          "id": 55099,
          "text": "<p><span style=\"font-size:12.0pt;\">Thalamus</span></p>"
        },
        {
          "id": 55100,
          "text": "<p><span style=\"font-size:12.0pt;\">Amygdala</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The structure marked with the black arrow in the given picture arises from the ……… (</span>AIIMS May 2018)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/02/ia-14.jpg\" alt=\"\" width=\"300\" height=\"217\"></span></p>",
      "unique_key": "Q7226488",
      "question_audio": null,
      "question_video": null,
      "map_id": 13056828,
      "difficulty_level": "beginner",
      "subjects_id": [
        3
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Hippocampus</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This is a coronal section of the brain and the marked structure is the fornix. It arises from the hippocampus and ends in the mammillary body of the hypothalamus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Hippocampus&nbsp;</strong>is located in the medial temporal lobe of the brain.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The hippocampus is critical for the formation and retrieval of memories, particularly episodic memories. It's also involved in spatial navigation. Damage or atrophy of the hippocampus can result in difficulties forming new memories. Conditions like Alzheimer's disease often exhibit significant hippocampal atrophy.</span></p><p><br><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Mamillary body</strong>:&nbsp;Part of the diencephalon, present at the base of the brain, posterior to the pituitary gland.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The mammillary bodies are primarily associated with memory processing. They receive projections from the hippocampus via the fornix and send projections to the anterior nucleus of the thalamus. They're particularly involved in the recall of past memories and are thought to play a role in spatial memory. Damage to the mammillary bodies, often due to thiamine (vitamin B1) deficiency as seen in Wernicke-Korsakoff syndrome, can lead to memory deficits.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Thalamus: </strong>Positioned centrally in the brain, the thalamus is a large mass of gray matter deep within the brain. It is part of the diencephalon.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Often referred to as the \"relay station\" of the brain, the thalamus receives sensory and motor signals and relays them to the cerebral cortex. It's involved in consciousness, sleep, and alertness. Thalamic strokes or lesions can lead to sensory deficits, altered consciousness, and movement disorders.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Amygdala</strong>: Located in the anterior portion of the temporal lobe, deep within the brain.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The amygdala plays a pivotal role in processing emotions, particularly fear and pleasure. It helps determine which memories are stored and where they are stored based on emotional significance. Dysfunction of the amygdala can lead to various emotional and behavioral abnormalities. It's also implicated in conditions such as anxiety disorders and post-traumatic stress disorder (PTSD).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Coronal Section of Brain</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/02/ia-15.jpg\" alt=\"\" width=\"500\" height=\"254\"></span></p>",
      "correct_choice_id": 55098,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59568,
      "choices": [
        {
          "id": 237585,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Anaphylactic shock</span></span></span></p>"
        },
        {
          "id": 237586,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Septic shock</span></span></span></p>"
        },
        {
          "id": 237587,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Local anesthetic systemic toxicity (LAST)</span></span></span></p>"
        },
        {
          "id": 237588,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Myocardial infarction</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 32-year-old man is brought to the emergency department after collapsing suddenly at a clinic where he had undergone a minor procedure under local anesthesia. Upon arrival, he is unresponsive with a blood pressure of 70/40 mm Hg and a heart rate of 130 beats per minute. During the resuscitation process, he develops cardiac arrhythmias and seizures. His condition rapidly deteriorates despite initial supportive measures. A 20% Intralipid injection is administered as part of the resuscitation efforts, leading to gradual stabilization of his symptoms. What is the most likely diagnosis in this patient?</span></span></span></p>",
      "unique_key": "Q3412972",
      "question_audio": null,
      "question_video": null,
      "map_id": 13056829,
      "difficulty_level": "beginner",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Answer: C) Local anesthetic systemic toxicity (LAST)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Local anesthetic systemic toxicity (LAST) occurs when local anesthetics are inadvertently administered into the bloodstream or absorbed systemically at toxic levels. This can lead to central nervous system symptoms like seizures and cardiovascular collapse, including severe hypotension and arrhythmias. Intralipid (20% lipid emulsion) is used specifically in LAST as a rescue therapy. It acts as a lipid sink, binding the anesthetic and reducing its concentration in the plasma, thereby reversing the toxic effects and stabilizing the patient.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A) Anaphylactic shock:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Typically presents with hypotension, bronchospasm, and rash after allergen exposure and is treated primarily with epinephrine, not Intralipid.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B) Septic shock:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Associated with severe infection, systemic inflammatory response, and is treated with fluids, antibiotics, and vasopressors, not lipid emulsions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D) Myocardial infarction:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Characterized by chest pain, ECG changes, and elevated cardiac enzymes, managed with antiplatelets, anticoagulants, and reperfusion strategies, not with Intralipid therapy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Local anesthetic systemic toxicity (LAST) is a potentially life-threatening condition characterized by neurological and cardiovascular manifestations due to excessive local anesthetic absorption. 20% Intralipid therapy is a key treatment modality for LAST, acting as a lipid sink to reduce circulating levels of the anesthetic and reverse toxicity.</span></span></span></p>",
      "correct_choice_id": 237587,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44029,
      "choices": [
        {
          "id": 175775,
          "text": "<p><span style=\"font-size:12pt;\">Nocardia acid fast stain</span></p>"
        },
        {
          "id": 175776,
          "text": "<p><span style=\"font-size:12pt;\">Streptococcus gram stain</span></p>"
        },
        {
          "id": 175777,
          "text": "<p><span style=\"font-size:12pt;\">Cryptococcus india ink</span></p>"
        },
        {
          "id": 175778,
          "text": "<p><span style=\"font-size:12pt;\">Coccidioidomycosis PAS stain</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the organism and the staining method used in the provided image. (INICET NOV 2023)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/16/screenshot-2024-05-16-183830.JPG\" alt=\"\" width=\"300\" height=\"215\"></span></p>",
      "unique_key": "Q6861154",
      "question_audio": null,
      "question_video": null,
      "map_id": 13056830,
      "difficulty_level": "beginner",
      "subjects_id": [
        6
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Nocardia acid fast stain</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The image shows filamentous bacteria with partial acid-fastness, characteristic of Nocardia species stained using an acid-fast technique.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Streptococcus gram stain</strong>: Shows gram-positive cocci, not filamentous bacteria.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Cryptococcus india ink</strong>: Would reveal spherical yeast forms with a clear halo.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Coccidioidomycosis PAS stain</strong>: Typically shows spherules rather than filamentous structures.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Nocardia species are identified using an acid-fast stain, which highlights their filamentous and partially acid-fast nature.</span></p>",
      "correct_choice_id": 175775,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3510,
      "choices": [
        {
          "id": 14019,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tzanck cells</span></span></span></p>"
        },
        {
          "id": 14020,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pund cells</span></span></span></p>"
        },
        {
          "id": 14021,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Henderson-Patterson bodies</span></span></span></p>"
        },
        {
          "id": 14022,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Guarnieri bodies</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A young male presents to the STD clinic with painful lesions as shown in the image. What is the most likely microscopic finding of the lesion?</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:10.5pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">INICET MAY 2020)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/30/untitled-262.jpg\" style=\"height:279px; width:400px\" /></span></span></span></p>",
      "unique_key": "Q4381964",
      "question_audio": null,
      "question_video": null,
      "map_id": 13056831,
      "difficulty_level": "intermediate",
      "subjects_id": [
        6
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Tzanck cells</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The clinical picture is suggestive of <strong>genital herpes. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tzanck cells &ndash; multinucleate giant cells seen on Tzanck smear in herpes simplex virus infection.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Herpetic lesions usually begin as clusters of small bumps, then blisters, followed by open sores or ulcers. Lesions coalesce and usually heal over several weeks at various rates. <strong>Local pain</strong> is a prominent and common complaint. Patients with genital herpes may also complain of <strong>pain in the groin area secondary to local adenopathy.</strong> Women often present with complaints of genital swelling, discharge, and dysuria.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Pund cells: Donovan bodies&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">are seen within large, mononuclear (Pund) cells as gram-negative intracytoplasmic cysts filled with deeply staining bodies<strong>. Seen in granuloma inguinale (donovanosis)</strong> which is a genital ulcerative disease caused by the intracellular gram-negative bacterium <strong>Klebsiella granulomatis (</strong>formerly known as Calymmatobacterium granulomatis).</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Donovanosis lesions usually start as a <strong>painless papule or subcutaneous nodule</strong>. The lesions develop the classic &ldquo;<strong>beefy-red&rdquo; appearance</strong> due to their high vascularity. The initial lesion takes on an ulcerative morphology after minor trauma. There is usually no regional lymphadenopathy. Developing <strong>subcutaneous granulomas known as pseudo buboes is possible.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/30/untitled-263.jpg\" style=\"height:195px; width:258px\" /></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Henderson-Patterson bodies: intracytoplasmic inclusion&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">bodies (molluscum bodies, or Henderson-Paterson bodies) are seen <strong>in molluscum contagiosum</strong>. Lesions are <strong>painless, discrete</strong>, nontender, flesh-colored, <strong>dome-shaped papules (bumps, dimples</strong>) that show a <strong>central umbilication.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/30/untitled-264.jpg\" style=\"height:255px; width:326px\" /></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Guarnieri bodies</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: B-type inclusions, formerly known as Guarnieri bodies are cellular features found upon microscopic inspection of epithelial cells of individuals suspected of <strong>having poxvirus or vaccinia virus.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The presence of Tzanck cells, which are multinucleated giant cells, is indicative of herpes simplex virus infection. This is the most likely microscopic finding in a patient with painful genital lesions consistent with genital herpes.</span></span></span></p>",
      "correct_choice_id": 14019,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6463,
      "choices": [
        {
          "id": 25821,
          "text": "<p><span style=\"font-size:12.0pt;\">Highly bound to plasma proteins</span></p>"
        },
        {
          "id": 25822,
          "text": "<p><span style=\"font-size:12.0pt;\">Confined to vascular compartment</span></p>"
        },
        {
          "id": 25823,
          "text": "<p><span style=\"font-size:12.0pt;\">Sequestered in body tissues</span></p>"
        },
        {
          "id": 25824,
          "text": "<p><span style=\"font-size:12.0pt;\">Both A and B</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Apparent volume of distribution of a drug is very high (6L/kg). Which of the following is true regarding the distribution of that drug? (NEET PG 2019)</span></p>",
      "unique_key": "Q7391971",
      "question_audio": null,
      "question_video": null,
      "map_id": 13056832,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Sequestered in body tissues</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">A Vd (volume of distribution) of 6 L/kg means approx. 420 L (6 x 70) in a 70 Kg person. It is much higher than blood volume of 5L.</span></li><li><span style=\"font-size:12.0pt;\">A high Vd suggests that the drug is extensively distributed beyond the blood and into the tissues. This often implies that the drug has a high affinity for tissues, effectively getting \"sequestered\" or stored there.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Highly bound to plasma proteins</strong>: A drug that is highly bound to plasma proteins would typically have a lower Vd because it is mostly confined to the bloodstream. Plasma protein binding keeps the drug within the vascular space, preventing its distribution into tissues.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Confined to vascular compartment</strong>: A low Vd would suggest that the drug is primarily in the vascular compartment, including plasma and blood cells. A high Vd of 6L/kg indicates the opposite, suggesting that the drug is widely distributed in tissues rather than confined to the vascular compartment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Therefore, a high Vd suggests that the drug is stored or sequestered in various body tissues, making option C the correct answer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A high volume of distribution (Vd) suggests that the drug is widely distributed throughout the body and sequestered in various tissues, rather than being confined to the bloodstream or vascular compartment.</span></p>",
      "correct_choice_id": 25823,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59569,
      "choices": [
        {
          "id": 237589,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Niacin</span></span></span></p>"
        },
        {
          "id": 237590,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pantothenic</span></span></span></p>"
        },
        {
          "id": 237591,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cyanocobala</span></span></span></p>"
        },
        {
          "id": 237592,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Folic acid</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which vitamin can be synthesized internally by humans? (AIIMS NOV 2016)</span></span></span></p>",
      "unique_key": "Q4732397",
      "question_audio": null,
      "question_video": null,
      "map_id": 13056833,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Answer: A. Niacin</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Niacin, unlike most vitamins, can be synthesized endogenously from the amino acid tryptophan. This synthesis involves a complex biochemical pathway that converts tryptophan to nicotinic acid and nicotinamide, the active forms of niacin. These forms serve crucial roles in oxidation-reduction reactions as components of the coenzymes NAD and NADP. Niacin deficiency can lead to pellagra, a condition characterized by the &quot;3 Ds&quot;: dermatitis (skin inflammation), diarrhea, and dementia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Pantothenic Acid:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This vitamin is essential and must be consumed through the diet as it cannot be synthesized by the body.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Cyanocobalamin (Vitamin B12):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Humans cannot synthesize Vitamin B12; it must be ingested, with sources primarily being animal-based foods.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Folic Acid:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This is another essential vitamin that must be obtained from dietary sources, especially green leafy vegetables.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Niacin can be synthesized in the human body from tryptophan, making it unique among vitamins.</span></span></span></p>",
      "correct_choice_id": 237589,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7109,
      "choices": [
        {
          "id": 28404,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Timolol</span></span></span></p>"
        },
        {
          "id": 28405,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Netarsudil</span></span></span></p>"
        },
        {
          "id": 28406,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Brimonidine</span></span></span></p>"
        },
        {
          "id": 28407,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Acetazolamide</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following drugs increases trabecular outflow?</span></span>(INICET MAY 2022)</p>",
      "unique_key": "Q3770546",
      "question_audio": null,
      "question_video": null,
      "map_id": 13056834,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B. Netarsudil </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Netarsudil is used in the treatment of glaucoma, it is a Rho-kinase inhibitor that acts by increasing the trabecular outflow. The other drugs that act by increasing the trabecular outflow are the miotic drugs like Pilocarpine, Physostigmine and Ecothiophate.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"><br />\r\n<span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Option A.</strong> <strong>Timolol: I</strong>s a non-selective Beta blocker which is used in treatment of glaucoma. It acts by reducing the aqueous formation.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong> Brimonidine:</strong>&nbsp;Is a topical alpha-receptor agonist. It acts by increasing the uveoscleral outflow and reduces the aqueous formation</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D.&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Acetazolamide:</strong>&nbsp;Is a carbonic anhydrase inhibitor which reduces aqueous formation</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Netarsudil is effective in treating glaucoma by increasing trabecular outflow. This mechanism distinguishes it from other drugs like Timolol, Brimonidine, and Acetazolamide, which primarily reduce aqueous humor production or increase uveoscleral outflow.</span></span></span></p>",
      "correct_choice_id": 28405,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11199,
      "choices": [
        {
          "id": 44762,
          "text": "<p><span style=\"font-size:18px;\">3 iron and folic acid (IFA) tablets, taken OD</span></p>"
        },
        {
          "id": 44763,
          "text": "<p><span style=\"font-size:18px;\">IV iron sucrose for non-compliance with oral tablets</span></p>"
        },
        {
          "id": 44764,
          "text": "<p><span style=\"font-size:18px;\">2 iron and folic acid tablets OD + IV iron sucrose</span></p>"
        },
        {
          "id": 44765,
          "text": "<p><span style=\"font-size:18px;\">IM ferric carboxy maltose (FCM)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>A pregnant woman presenting at less than 34 weeks of gestation displays signs of mild to moderate anemia. Under the \"Anemia Mukh Bharat\" initiative, which therapeutic approach would be the most appropriate? </strong><i><strong>[INICET NOV 2022]</strong></i></span></p>",
      "unique_key": "Q9952919",
      "question_audio": null,
      "question_video": null,
      "map_id": 13056835,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (b) IV iron sucrose for non-compliance with oral tablets</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The best treatment among the given options is IV iron sucrose for non-compliance with oral tablets.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Severity of Anemia according to Anemia Mukt Bharat campaign,</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Mild – 10-10.9 g%</span></li><li><span style=\"font-size:18px;\">Moderate – 7-9 g%</span></li><li><span style=\"font-size:18px;\">Severe – &lt;7 g %</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Testing and treating Mild and Moderate Anemia:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">If mild anemia OR moderate anemia: Give 2 tablets of iron and folic acid</span></li><li><span style=\"font-size:18px;\">If patient presents late in pregnancy or is unable to tolerate oral iron: Parenteral iron – IV Iron sucrose or Ferric carboxymaltose (FeCM).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Treating Severe anemia:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Hb &lt; 7g%: Parenteral iron – IV Iron sucrose or Ferric carboxymaltose (FeCM).</span></li><li><span style=\"font-size:18px;\">If patient presents late in the third trimester with severe anemia or Hb is less than 5 g%: ADMIT</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong><u>Anemia Mukt Bharat (2018)</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Aim: Reduce anemia by 3% per year</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">6 x 6 x 6 strategy</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/27/psm-pyq-17.jpg\" alt=\"\" width=\"558\" height=\"101\"></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/27/picture10777.jpg\" alt=\"\" width=\"500\" height=\"369\"></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/27/picture1133.jpg\" alt=\"\" width=\"800\" height=\"425\"></span></p>",
      "correct_choice_id": 44763,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11428,
      "choices": [
        {
          "id": 45678,
          "text": "<p><span style=\"font-size:12.0pt;\">SIADH</span></p>"
        },
        {
          "id": 45679,
          "text": "<p><span style=\"font-size:12.0pt;\">Diuretic induced hyponatremia</span></p>"
        },
        {
          "id": 45680,
          "text": "<p><span style=\"font-size:12.0pt;\">Cerebral salt wasting syndrome</span></p>"
        },
        {
          "id": 45681,
          "text": "<p><span style=\"font-size:12.0pt;\">Pseudohyponatremia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 40-year-old smoker who is a known case of hypertension was on enalapril and hydrochlorothiazide. He had an episode of hemoptysis and on evaluation, he was found to have bronchogenic carcinoma with brain metastasis. His lab values were Na-124mg/dL, creatinine - 2.8mg%, blood sugar 112mg/dL, blood urea - 24mg/dL, serum osmolality 255mosm, urine osmolality - 110 mosm, 24-hour urinary sodium - 110 and BP - 150/90 mmHg.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Which of the following is the most probable diagnosis of the low sodium values in him? (AIIMS MAY 2018)</span></p>",
      "unique_key": "Q7098483",
      "question_audio": null,
      "question_video": null,
      "map_id": 13056836,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) SIADH</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) is the most probable diagnosis in this patient. The diagnostic criteria and the patient's clinical presentation support this conclusion:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/picture31.jpg\" alt=\"\" width=\"1000\" height=\"267\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Additionally, lung cancer (specifically bronchogenic carcinoma) can often cause SIADH, either through ectopic production of antidiuretic hormone (ADH) or related paraneoplastic syndromes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Diuretic induced hyponatremia:</strong> Incorrect because the pattern of serum and urine osmolality does not align solely with diuretic use; the high urine sodium and euvolemia are more indicative of SIADH.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Cerebral salt wasting syndrome:</strong> Incorrect as this condition typically presents with hypovolemia and low blood pressure due to significant sodium and fluid loss, which is not evident in this patient who maintains a normal blood pressure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Pseudohyponatremia:</strong> Incorrect because the reduced serum osmolality directly indicates true hyponatremia, not a distortion caused by high levels of lipids or proteins in the blood.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">SIADH can be associated with malignancies like lung cancer, presenting with hyponatremia, low serum osmolality, and inappropriately concentrated urine despite the presence of low plasma osmolality. This clinical scenario should prompt consideration of SIADH, particularly in patients with known malignancies and typical lab findings.</span></p>",
      "correct_choice_id": 45678,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6529,
      "choices": [
        {
          "id": 26085,
          "text": "<p><span style=\"font-size:12.0pt;\">Octreotide</span></p>"
        },
        {
          "id": 26086,
          "text": "<p><span style=\"font-size:12.0pt;\">Pegvisomant</span></p>"
        },
        {
          "id": 26087,
          "text": "<p><span style=\"font-size:12.0pt;\">Cabergoline</span></p>"
        },
        {
          "id": 26088,
          "text": "<p><span style=\"font-size:12.0pt;\">Olcegepant</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A middle-aged male patient presents with chin protrusion, excessive sweating, impaired glucose tolerance, and hand and foot enlargement. What is a growth hormone receptor antagonist used to treat this condition?</span> <span style=\"font-size:12.0pt;\">(NEET PG 2022)</span></p>",
      "unique_key": "Q1518613",
      "question_audio": null,
      "question_video": null,
      "map_id": 13057057,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Pegvisomant</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient's symptoms suggest acromegaly, a condition characterized by excessive growth hormone (GH) secretion, usually due to a pituitary adenoma. Pegvisomant is a growth hormone receptor antagonist used in the treatment of acromegaly. It blocks the effects of growth hormone at the receptor level, leading to decreased levels of insulin-like growth factor-1 (IGF-1), which is responsible for the acromegaly symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Octreotide</strong>: Octreotide is a somatostatin analogue, which can be used in the treatment of acromegaly. It works by inhibiting the release of growth hormone from the pituitary gland. However, it is not a growth hormone receptor antagonist; instead, it reduces GH secretion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Cabergoline</strong>: Cabergoline is a dopamine agonist primarily used in the treatment of prolactinomas, another type of pituitary adenoma. It is not typically used as a first-line treatment for acromegaly and does not act as a growth hormone receptor antagonist.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Olcegepant</strong>: Olcegepant is a calcitonin gene-related peptide receptor antagonist used in the research for migraine treatment. It is not used in the treatment of acromegaly or related to growth hormone activity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Pegvisomant is a growth hormone receptor antagonist used to treat acromegaly by blocking the effects of growth hormone at the receptor level, thereby reducing the symptoms associated with elevated growth hormone levels.</span></p>",
      "correct_choice_id": 26086,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 1924,
      "choices": [
        {
          "id": 7689,
          "text": "<p><span style=\"font-size:12.0pt;\">Hormone-sensitive lipase</span></p>"
        },
        {
          "id": 7690,
          "text": "<p><span style=\"font-size:12.0pt;\">Glycogen phosphorylase</span></p>"
        },
        {
          "id": 7691,
          "text": "<p><span style=\"font-size:12.0pt;\">Pyruvate carboxylase</span></p>"
        },
        {
          "id": 7692,
          "text": "<p><span style=\"font-size:12.0pt;\">Phosphofructokinase 1</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following enzyme activity decreases in fasting? (</span>AIIMS May 2018)</p>",
      "unique_key": "Q8897873",
      "question_audio": null,
      "question_video": null,
      "map_id": 13057058,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Phosphofructokinase 1</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Phosphofructokinase 1 (PFK-1) is a key regulatory enzyme in glycolysis that catalyzes the conversion of fructose-6-phosphate to fructose-1,6-bisphosphate. Its activity is increased in the fed state and decreased during fasting. During fasting, the body's metabolic state shifts to prioritize gluconeogenesis and fatty acid oxidation, leading to a decrease in glycolytic enzyme activities, including PFK-1.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Hormone-sensitive lipase:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\"><strong>Activity:</strong> Increases during fasting.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Function:</strong> Mobilizes fatty acids from adipose tissue by breaking down triglycerides.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Glycogen phosphorylase:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\"><strong>Activity:</strong> Increases during fasting.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Function:</strong> Breaks down glycogen to glucose-1-phosphate in the liver and muscles, providing glucose during fasting.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Pyruvate carboxylase:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\"><strong>Activity:</strong> Increases during fasting.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Function:</strong> Catalyzes the conversion of pyruvate to oxaloacetate, a key step in gluconeogenesis.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/06/screenshot-2024-06-06-122001_pKklJhK.jpg\" alt=\"\" width=\"1000\" height=\"663\"></p>",
      "correct_choice_id": 7692,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11088,
      "choices": [
        {
          "id": 44318,
          "text": "<p><span style=\"font-size:18px;\">&gt;0.1 IU/ml</span></p>"
        },
        {
          "id": 44319,
          "text": "<p><span style=\"font-size:18px;\">&gt;0.01 IU/ml</span></p>"
        },
        {
          "id": 44320,
          "text": "<p><span style=\"font-size:18px;\">&gt;0.001 IU/ml</span></p>"
        },
        {
          "id": 44321,
          "text": "<p><span style=\"font-size:18px;\">&gt;0.0001 IU/ml</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>What concentration of tetanus antitoxin in the blood is considered clinically protective against tetanus? </strong><i><strong>[AIIMS MAY 2020]</strong></i></span></p>",
      "unique_key": "Q1313469",
      "question_audio": null,
      "question_video": null,
      "map_id": 13057059,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (b) &gt;0.01 IU/ml</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Specific antibody concentrations greater than 0.01 IU/mL were considered protective against tetanus.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Aim of active Immunisation with TT:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Vaccinate the entire community</span></li><li><span style=\"font-size:18px;\">Ensure protective level of antitoxin ~ 0.01 IU/mL serum throughout life</span></li></ul>",
      "correct_choice_id": 44319,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10191,
      "choices": [
        {
          "id": 40730,
          "text": "<p><span style=\"font-size:18px;\">Line graph</span></p>"
        },
        {
          "id": 40731,
          "text": "<p><span style=\"font-size:18px;\">Histogram</span></p>"
        },
        {
          "id": 40732,
          "text": "<p><span style=\"font-size:18px;\">Ogive</span></p>"
        },
        {
          "id": 40733,
          "text": "<p><span style=\"font-size:18px;\">Stem and leaf plot</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>What method is most effective for visually representing the fluctuations in disease occurrence within a given area over time? </strong><i><strong>[NEET PG 2019]</strong></i></span></p>",
      "unique_key": "Q8647703",
      "question_audio": null,
      "question_video": null,
      "map_id": 13057060,
      "difficulty_level": "beginner",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (a) Line graph</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Line graphs or line diagrams are the best way to plot the changes in the incidence of a disease in a given area over time (TREND of any event).</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/65.jpg\" alt=\"\" width=\"500\" height=\"266\"></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B.</strong> <strong>Histogram: </strong>Is graphical presentation for ‘continuous quantitative data’</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Continuous groups are marked on x-axis (abscissa) while frequencies are marked on y-axis (ordinate).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/03/screenshot-2023-10-03-125430.jpg\" alt=\"\" width=\"500\" height=\"379\"></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Ogive:&nbsp;</strong> Is graph of cumulative relative frequency distribution</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/03/screenshot-2023-10-03-125431.jpg\" alt=\"\" width=\"500\" height=\"254\"></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Stem and leaf plot:&nbsp;</strong> Represents quantitative data in graphical format which helps us visualize the shape of distribution. We are able to represent frequencies for different classes of values.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/03/whatsapp-image-2023-10-03-at-123902.jpeg\" alt=\"\" width=\"500\" height=\"227\"></span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Line graphs are the most effective method for visually representing the fluctuations in disease occurrence over time, making them ideal for identifying and analyzing trends in epidemiological data.</span></p>",
      "correct_choice_id": 40730,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13087,
      "choices": [
        {
          "id": 52310,
          "text": "<p><span style=\"font-size:12.0pt;\">Refractive error</span></p>"
        },
        {
          "id": 52311,
          "text": "<p><span style=\"font-size:12.0pt;\">Untreated cataract</span></p>"
        },
        {
          "id": 52312,
          "text": "<p><span style=\"font-size:12.0pt;\">Glaucoma</span></p>"
        },
        {
          "id": 52313,
          "text": "<p><span style=\"font-size:12.0pt;\">Diabetic retinopathy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the most common cause of moderate-severe visual impairment according to the National Blindness and Visual Impairment Survey 2015-19?</span>(INICET MAY 2022)</p>",
      "unique_key": "Q2480386",
      "question_audio": null,
      "question_video": null,
      "map_id": 13057061,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Untreated cataract</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The National Blindness and Visual Impairment Survey conducted from 2015 to 2019 revealed that untreated cataract is the leading cause of moderate-severe visual impairment (MSVI). MSVI is characterized by a presenting visual acuity of &lt;6/18 to 3/60 in the better eye despite available correction. Visual impairment and blindness are frequently observed in individuals who are 50 years old and above.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A:</strong> Refractive errors are the leading cause of MSVI in patients aged 49 years and below.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Options C and&nbsp;Option&nbsp;D:</strong> Glaucoma and diabetic retinopathy account for a very low number of visual impairment cases in patients aged 50 years and above.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The prevalence of untreated cataracts as a leading cause of moderate-severe visual impairment emphasizes the need for effective public health strategies focusing on eye health screenings and accessible cataract surgery to reduce the burden of preventable blindness and visual impairment.</span></p>",
      "correct_choice_id": 52311,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5839,
      "choices": [
        {
          "id": 23326,
          "text": "<p><span style=\"font-size:12pt;\">USG to see cervical length</span></p>"
        },
        {
          "id": 23327,
          "text": "<p><span style=\"font-size:12pt;\">Cervical Cerclage</span></p>"
        },
        {
          "id": 23328,
          "text": "<p><span style=\"font-size:12pt;\">Complete Bed rest</span></p>"
        },
        {
          "id": 23329,
          "text": "<p><span style=\"font-size:12pt;\">Abdominal cerclage</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A G3P2L0 presents with 9 weeks of amenorrhea. She has a history of conization being done one year ago and is currently on follow-up, with no recurrence on PAP smear. She also has the history of preterm labor at 30 and 32 weeks. What is the next step of management?&nbsp;</span>(INICET NOV 2018)</p>",
      "unique_key": "Q1377356",
      "question_audio": null,
      "question_video": null,
      "map_id": 13057062,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) USG to see cervical length</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">This patient has several risk factors for preterm labor, including a history of previous preterm births and cervical conization. The appropriate next step in management is to perform a transvaginal ultrasound (USG) to measure the cervical length at 11-14 weeks of gestation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Key Points:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Cervical length measurement:</strong> If the cervix is found to be short (less than 2.5 cm), with or without funneling of the internal os, cervical cerclage may be indicated.</span></li><li><span style=\"font-size:12pt;\"><strong>Progesterone supplementation:</strong> If the cervical length is normal, the patient should be started on progesterone and serial cervical length measurements should be continued.</span></li><li><span style=\"font-size:12pt;\"><strong>Cervical cerclage:</strong> This is a procedure where a suture is placed around the cervix to prevent or delay preterm birth. It can be done via the vaginal route using techniques like McDonald’s or Shirodkar's.</span></li><li><span style=\"font-size:12pt;\"><strong>Abdominal cerclage:</strong> This is considered for patients with a prior failed vaginal cerclage.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Cervical Cerclage:</strong> While cerclage may be necessary, it should be based on the findings of cervical length measurement. Immediate cerclage without assessment is not recommended.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Complete Bed rest:</strong> Bed rest alone is not an effective strategy for preventing preterm labor and is not indicated without further assessment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Abdominal cerclage:</strong> This is reserved for patients with a history of failed vaginal cerclage and is not the first-line approach.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">For a patient with risk factors for preterm labor, including a history of cervical conization and previous preterm births, the next step is to perform a transvaginal ultrasound to measure cervical length at 11-14 weeks of gestation. Based on the findings, appropriate interventions, such as cervical cerclage or progesterone supplementation, can be considered.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: William’s textbook of obstetrics 26<sup>th</sup> edition pg2094</strong></span></p>",
      "correct_choice_id": 23326,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6020,
      "choices": [
        {
          "id": 24050,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Umbilical artery</span></span></span></p>"
        },
        {
          "id": 24051,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Umbilical vein</span></span></span></p>"
        },
        {
          "id": 24052,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ductus arteriosus</span></span></span></p>"
        },
        {
          "id": 24053,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ductus venosus</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Deoxygenated blood is returned to the placenta from the fetus through?</span></span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;</span></span>(NEET PG 2021)</p>",
      "unique_key": "Q4758402",
      "question_audio": null,
      "question_video": null,
      "map_id": 13057063,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Umbilical artery</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fetal circulation:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/15/13_I8JRiPg.jpg\" style=\"height:1449px; width:1000px\" /></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Umbilical vein:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carries oxygenated blood from the placenta to the fetus, not deoxygenated blood.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Ductus arteriosus:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Shunts blood from the pulmonary artery to the aorta in fetal circulation, bypassing the lungs. It does not return deoxygenated blood to the placenta.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Ductus venosus:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Shunts blood from the umbilical vein to the IVC, allowing oxygenated blood to bypass the liver. It does not return deoxygenated blood to the placenta.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Deoxygenated blood exits the fetus through the umbilical arteries, which return it to the placenta.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 343, Williams Obstetrics 26<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 24050,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "InvestigationBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59570,
      "choices": [
        {
          "id": 237593,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">RSI should be avoided in patients with a full stomach to prevent aspiration.</span></span></span></p>"
        },
        {
          "id": 237594,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">RSI involves preoxygenation and simultaneous administration of an induction agent and a paralytic agent.</span></span></span></p>"
        },
        {
          "id": 237595,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Bag-mask ventilation is routinely performed between induction and paralysis to ensure oxygenation.</span></span></span></p>"
        },
        {
          "id": 237596,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">RSI is primarily indicated in cardiac arrest patients who require intubation.</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 55-year-old man is brought to the emergency department with severe respiratory distress due to worsening pulmonary edema. He is visibly struggling to breathe, with labored respirations and low oxygen saturation despite supplemental oxygen. The medical team decides to perform rapid sequence intubation (RSI) to secure his airway. Which of the following statements about RSI is correct?</span></span></span></p>",
      "unique_key": "Q9500104",
      "question_audio": null,
      "question_video": null,
      "map_id": 13057064,
      "difficulty_level": "intermediate",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Answer: B) RSI involves preoxygenation and simultaneous administration of an induction agent and a paralytic agent.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Rapid sequence intubation (RSI) is a technique used to secure the airway in patients who are at high risk of aspiration, such as those with acute respiratory distress, trauma, or other emergent conditions. RSI is particularly valuable because it minimizes the time between the loss of protective airway reflexes and the placement of the endotracheal tube, thereby reducing the risk of aspiration.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Preoxygenation:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This step involves administering 100% oxygen for 3-5 minutes to fill the patient&rsquo;s lungs with oxygen, creating an oxygen reserve to minimize hypoxemia during the apneic period.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Simultaneous Administration of Medications:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> An induction agent (e.g., etomidate, propofol, ketamine) is given to induce unconsciousness, and a neuromuscular blocking agent (e.g., succinylcholine, rocuronium) is given to achieve paralysis. The simultaneous administration ensures rapid onset of unconsciousness and paralysis, facilitating quick and controlled intubation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Avoidance of Bag-Mask Ventilation:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Bag-mask ventilation is generally avoided between induction and intubation to prevent gastric insufflation and reduce the risk of aspiration, which is particularly critical in patients with a full stomach.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Intubation and Confirmation:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> The endotracheal tube is placed swiftly, and its position is confirmed using clinical assessment and tools like capnography.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Indications:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Patients at high risk of aspiration (e.g., with a full stomach, gastrointestinal bleeding).</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Severe respiratory distress or failure where airway control is critical.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Trauma patients needing immediate airway protection.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Contraindications:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Situations where the patient is already in cardiac arrest; intubation is prioritized without the use of drugs.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A) RSI should be avoided in patients with a full stomach to prevent aspiration:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This is incorrect because RSI is specifically designed for patients at risk of aspiration, including those with a full stomach, to quickly secure the airway and prevent gastric contents from entering the lungs.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C) Bag-mask ventilation is routinely performed between induction and paralysis to ensure oxygenation:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This is incorrect as routine bag-mask ventilation is avoided during RSI to prevent increasing the risk of aspiration due to gastric insufflation. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D) RSI is primarily indicated in cardiac arrest patients who require intubation:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This is incorrect because in cardiac arrest, securing the airway is done without delay and often without the need for induction agents or paralytics, as these patients are unresponsive.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Rapid sequence intubation (RSI) is a critical procedure for securing the airway in patients at high risk of aspiration. The key components include preoxygenation and simultaneous administration of an induction agent and a neuromuscular blocking agent, followed by immediate intubation without intermediate ventilation, ensuring rapid and safe airway control.</span></span></span></p>",
      "correct_choice_id": 237594,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9830,
      "choices": [
        {
          "id": 39287,
          "text": "<p><span style=\"font-size:12pt;\">No spontaneous remission is seen</span></p>"
        },
        {
          "id": 39288,
          "text": "<p><span style=\"font-size:12pt;\">Half of the cases resolve spontaneously after bacilli exposure</span></p>"
        },
        {
          "id": 39289,
          "text": "<p><span style=\"font-size:12pt;\">Spontaneous remission is more common in children than in adults</span></p>"
        },
        {
          "id": 39290,
          "text": "<p><span style=\"font-size:12pt;\">Indeterminate leprosy has more remission than tuberculoid leprosy</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which among the following is correct regarding the healing of leprosy if left untreated? (</span>INICET May 2021)</p>",
      "unique_key": "Q1699011",
      "question_audio": null,
      "question_video": null,
      "map_id": 13057065,
      "difficulty_level": "intermediate",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Indeterminate leprosy has more remission than tuberculoid leprosy.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Among the given options, Indeterminate leprosy has more remission than tuberculoid is the most appropriate answer</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The bacillus <strong>Mycobacterium leprae</strong> is the source of the chronic infectious granulomatous disease known as leprosy <strong>(Hansen's disease)</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Clinically, leprosy can exhibit one or more of the following symptoms</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Patches of<strong> hypopigmentation</strong></span></li><li><span style=\"font-size:12pt;\">Presence of <strong>thickened nerves</strong>, and</span></li><li><span style=\"font-size:12pt;\">Partial or complete <strong>loss of cutaneous sensation </strong>in the affected areas (First sensory modality to be lost is <strong><u>Temperature </u>(hot/cold&nbsp;</strong>differentiation).</span></li><li><span style=\"font-size:12pt;\">The presence of acid-fast bacilli in nasal smears or the skin.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Leprosy symptoms vary depending on how an individual's <strong>immune</strong> system reacts to the bacillus Mycobacterium leprae. <strong>Spontaneous resolution</strong> can be seen in about <strong>80–90% (</strong>NOT just 50% as given in Option B) of people after being exposed to bacteria. &nbsp;The remaining patients get clinical leprosy. Indeterminate leprosy typically has hypopigmented, ill-defined lesions. 75 percent of those Indeterminate leprosy patients experience spontaneous remission.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Clinically, very few patients exhibit either <strong>lepromatous</strong> leprosy or <strong>tuberculoid</strong> leprosy. As a result, compared to patients with tuberculoid leprosy, more patients with <strong>indeterminate</strong> leprosy experience <strong>spontaneous remission</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A.&nbsp;No spontaneous remission is seen: Incorrect.</strong> Spontaneous remission can occur in leprosy, particularly in the indeterminate and sometimes in the tuberculoid forms due to the individual's immune response.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Note - </strong>Even in the absence of specific treatment, a majority (80-90%) of patients tend to get cured spontaneously.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.&nbsp;Half of the cases resolve spontaneously after bacilli exposure. Incorrect.</strong> While many individuals may be exposed to <i>Mycobacterium leprae</i> and not develop full-blown leprosy due to a robust immune response, the assertion that half of the cases resolve spontaneously is not accurate. A higher percentage may never progress to clinical disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Spontaneous remission in children is variable when compared to adults.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Spontaneous remission occurs even in the absence of specific treatment in majority (almost 80-90%) of the patients, but when compared to adults,&nbsp;</strong>in <strong>children spontaneous cure</strong> is very much <strong>variable.</strong></span></li><li><span style=\"font-size:12pt;\"><strong>If left untreated, Indeterminate&nbsp;</strong>leprosy has a higher rate of <strong>spontaneous remission</strong> compared to tuberculoid leprosy.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref - Rook's Textbook of Dermatology 9th edition, Page no 28.7</strong></span></p><p><span style=\"font-size:12pt;\"><strong>Parks textbook of preventive &amp; social medicine 26<sup>th</sup> edition Pg 359</strong></span></p>",
      "correct_choice_id": 39290,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3451,
      "choices": [
        {
          "id": 13783,
          "text": "<p><span style=\"font-size:12.0pt;\">Cryptococcus neoformans</span></p>"
        },
        {
          "id": 13784,
          "text": "<p><span style=\"font-size:12.0pt;\">Histoplasma capsulatum</span></p>"
        },
        {
          "id": 13785,
          "text": "<p><span style=\"font-size:12.0pt;\">Sporothrix schenckii</span></p>"
        },
        {
          "id": 13786,
          "text": "<p><span style=\"font-size:12.0pt;\">Talaromyces marneffei</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which among the following is a subcutaneous fungal agent? (INICET MAY 2019)</span></p>",
      "unique_key": "Q4815643",
      "question_audio": null,
      "question_video": null,
      "map_id": 13057066,
      "difficulty_level": "beginner",
      "subjects_id": [
        6
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Sporothrix schenckii</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Sporothrix schenckii</strong> is a subcutaneous fungal agent. It is the causative agent of sporotrichosis, commonly known as \"rose gardener's disease.\" This fungal infection occurs when the fungus, which lives in soil, plants, and decaying vegetation, enters the skin through small cuts or punctures. The infection usually starts as a small nodule at the site of entry and can spread along lymphatic channels, causing nodular lesions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Cryptococcus neoformans</strong>: This fungus is typically associated with systemic infections, particularly cryptococcal meningitis, in immunocompromised individuals, especially those with HIV/AIDS. It is not classified as a subcutaneous fungal agent.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Histoplasma capsulatum</strong>: This is a systemic mycotic agent that causes histoplasmosis, a respiratory infection that can disseminate in immunocompromised individuals. It is not a subcutaneous fungal agent.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Talaromyces marneffei</strong>: Formerly known as Penicillium marneffei, this fungus causes systemic mycoses, particularly in immunocompromised patients such as those with HIV/AIDS. It is endemic in Southeast Asia and not classified as a subcutaneous fungal agent.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/30/1-micro-21.jpg\" alt=\"\" width=\"700\" height=\"540\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The term systemic mycoses is used here to refer to infections caused by organisms in the following genera: Blastomyces, Coccidioides, Paracoccidioides, Histoplasma, and Cryptococcus.</span></p>",
      "correct_choice_id": 13785,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5995,
      "choices": [
        {
          "id": 23950,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-A, 2-D, 3-C, 4-B</span></span></span></p>"
        },
        {
          "id": 23951,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿1-D, 2-B, 3-C, 4-A</span></span></span></p>"
        },
        {
          "id": 23952,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿1-C, 2-D, 3-B, 4-A</span></span></span></p>"
        },
        {
          "id": 23953,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿1-A, 2-B, 3-D, 4-C</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Match the following disorders causing secondary amenorrhea with their respective lab findings:&nbsp;</span></span>&nbsp;(INICET NOV 2021)</p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/07/screenshot-2024-08-07-172314.png\" style=\"height:196px; width:600px\" /></p>",
      "unique_key": "Q5091772",
      "question_audio": null,
      "question_video": null,
      "map_id": 13057067,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) 1-A, 2-D, 3-C, 4-B</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Secondary amenorrhea is the absence of menses for more than three months in girls or women who previously had regular menstrual cycles or six months in girls or women who had irregular menses.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Premature Ovarian failure: FSH and LH levels will be very high, estrogen levels are low</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Asherman&#39;s syndrome: As the cause in the endometrium, hormonal levels are normal.&nbsp; </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PCOS: Alteration in the LH/FSH ratio</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sheehan&#39;s syndrome/ pituitary apoplexy: Hypogonadotrophic hypogonadism: So FSH and LH are low and so is Estrogen</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">To correctly diagnose the underlying cause of secondary amenorrhea, it is essential to understand and interpret the hormonal profiles associated with different conditions:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Premature Ovarian Failure:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Elevated FSH and LH levels with decreased estradiol indicate ovarian insufficiency.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Asherman Syndrome:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Low levels of FSH, LH, and estradiol suggest an endometrial cause, such as scarring.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PCOS (Polycystic Ovary Syndrome):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Typically characterized by normal FSH, elevated LH, and normal estradiol levels, reflecting an imbalance in gonadotropins.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sheehan Syndrome:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Normal levels of FSH, LH, and estradiol are indicative of pituitary insufficiency, where the pituitary gland fails to stimulate the ovaries.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: William&rsquo;s textbook of gynecology 3<sup>rd</sup> edition Pg 380,</span></strong></span></span></p>",
      "correct_choice_id": 23950,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13903,
      "choices": [
        {
          "id": 55573,
          "text": "<p><span style=\"font-size:12.0pt;\">T1 - T2</span></p>"
        },
        {
          "id": 55574,
          "text": "<p><span style=\"font-size:12.0pt;\">T2 - T3</span></p>"
        },
        {
          "id": 55575,
          "text": "<p><span style=\"font-size:12.0pt;\">T3 - T4</span></p>"
        },
        {
          "id": 55576,
          "text": "<p><span style=\"font-size:12.0pt;\">T4 - T5</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the level of the cross-section shown in the image below. (</span>INICET Nov 2020)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/ia-103.jpg\" alt=\"\" width=\"325\" height=\"246\"></span></p>",
      "unique_key": "Q4894011",
      "question_audio": null,
      "question_video": null,
      "map_id": 13057068,
      "difficulty_level": "intermediate",
      "subjects_id": [
        3
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. T4-T5</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The cross-section shown in the image is at the level of T4-T5.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Ascending and Descending aorta are visible separately along with bifurcation of pulmonary trunk, this implies it is the section of T4-T5 level.</span></p><p>&nbsp;</p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/ia-104.jpg\" alt=\"\" width=\"600\" height=\"422\"></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Options A, Option B:</strong> In cross-sections at the levels of T1-T2 and T2-T3, only the small vascular openings of the branches arising from the arch of aorta would be visible.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C: In cross section of T3-T4 level &nbsp;- </strong>section of arch of aorta along with branches of arch of aorta would be visible</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"background-color:white;color:#0d0d0d;font-size:12.0pt;\">Bifurcation of pulmonary trunk along with separate ascending and descending aorta are clearing pointing towards T4-T5 level.</span></p>",
      "correct_choice_id": 55575,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21458,
      "choices": [
        {
          "id": 85796,
          "text": "<p><span style=\"font-size:12.0pt;\">Minimal change disease</span></p>"
        },
        {
          "id": 85797,
          "text": "<p><span style=\"font-size:12.0pt;\">Membranous glomerulopathy</span></p>"
        },
        {
          "id": 85798,
          "text": "<p><span style=\"font-size:12.0pt;\">Focal segmental glomerulosclerosis</span></p>"
        },
        {
          "id": 85799,
          "text": "<p><span style=\"font-size:12.0pt;\">Renal amyloidosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 50-year-old patient has malaise for 2 weeks. His investigations revealed an elevated creatinine of 4.5mg/dl. His blood tests also showed the presence of HBs antigen. A renal biopsy was performed which demonstrated spike and dome on special staining. Which of the following conditions is the patient likely to be suffering from?</span> <span style=\"font-size:12.0pt;\">(NEET PG 2023)</span></p>",
      "unique_key": "Q6389040",
      "question_audio": null,
      "question_video": null,
      "map_id": 13057069,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Membranous glomerulopathy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The elderly patient is having a renal dysfunction. The presence of a ‘spike and dome’ pattern on special staining (silver staining) is suggestive of immune complex deposition. This is characteristic of membranous glomerulopathy. The diagnosis isd also supported by the presence of HBs antigen as the hepatitis B infection is characteristically associated with development of membranous glomerulopathy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Minimal change disease:&nbsp;</strong>Typically presents with nephrotic syndrome in children and does not show the spike and dome pattern on biopsy. No change on light microscopy; Electron microscopy shows podocyte effacement</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Focal segmental glomerulosclerosis:&nbsp;</strong>Characterized by segmental scarring of some glomeruli, not associated with the spike and dome pattern.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Renal amyloidosis:&nbsp;</strong>Demonstrates amyloid deposits that can be identified with Congo red staining and apple-green birefringence under polarized light, not a spike and dome pattern.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Membranous glomerulopathy, associated with hepatitis B infection, presents with nephrotic syndrome and demonstrates a characteristic spike and dome pattern on renal biopsy due to subepithelial immune complex deposits.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Histology:</strong> Diffuse thickening of the glomerular basement membrane (GBM)</span></p>",
      "correct_choice_id": 85797,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54796,
      "choices": [
        {
          "id": 218649,
          "text": "<p><span style=\"font-size:12.0pt;\">Insulin</span></p>"
        },
        {
          "id": 218650,
          "text": "<p><span style=\"font-size:12.0pt;\">Thyroxine</span></p>"
        },
        {
          "id": 218651,
          "text": "<p><span style=\"font-size:12.0pt;\">Insulin-like growth factor</span></p>"
        },
        {
          "id": 218652,
          "text": "<p><span style=\"font-size:12.0pt;\">Growth hormone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which hormone is not responsible for intrauterine growth? (INICET MAY 2024)</span></p>",
      "unique_key": "Q4982764",
      "question_audio": null,
      "question_video": null,
      "map_id": 13057237,
      "difficulty_level": "beginner",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Growth hormone</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Growth hormone (GH) plays a crucial role in postnatal growth and development, but it is not significant during intrauterine (fetal) growth. During fetal development, the receptors for growth hormone are not sufficiently developed, which limits its ability to influence growth in utero. Instead, other hormones such as insulin, thyroxine, and insulin-like growth factors (IGFs) are critical for intrauterine growth.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Insulin</strong>: This hormone is essential for fetal growth as it promotes the storage of glucose and fats, providing energy for developing tissues.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Thyroxine</strong>: Thyroid hormones, particularly thyroxine, are crucial for both physical growth and brain development during fetal life.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Insulin-like Growth Factor (IGF)</strong>: IGFs, particularly IGF-2 during fetal life (and IGF 1 in adult life), play a significant role in promoting cellular growth and development. IGFs are produced in response to fetal pituitary signals but are the main drivers of growth, not GH itself.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Growth hormone is not responsible for intrauterine growth due to the underdeveloped nature of its receptors in the fetus, making insulin, thyroxine, and IGFs the primary hormones for fetal growth.</span></p>",
      "correct_choice_id": 218652,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11369,
      "choices": [
        {
          "id": 45442,
          "text": "<p><span style=\"font-size:12.0pt;\">Isoniazid, rifampicin, and fluoroquinolone</span></p>"
        },
        {
          "id": 45443,
          "text": "<p><span style=\"font-size:12.0pt;\">Fluoroquinolones</span></p>"
        },
        {
          "id": 45444,
          "text": "<p><span style=\"font-size:12.0pt;\">Isoniazid and rifampicin</span></p>"
        },
        {
          "id": 45445,
          "text": "<p><span style=\"font-size:12.0pt;\">Isoniazid, rifampicin, and kanamycin</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Multidrug-resistant (MDR) TB shows resistance to which of the following drugs? (Neet pg 2022)</span></p>",
      "unique_key": "Q8746531",
      "question_audio": null,
      "question_video": null,
      "map_id": 13057238,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Isoniazid and rifampicin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Multidrug-resistant tuberculosis (MDR-TB) is defined by its resistance to at least isoniazid and rifampicin, which are the two most powerful first-line anti-TB drugs. This resistance makes MDR-TB more difficult and longer to treat than drug-susceptible TB.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Isoniazid and rifampicin</strong>: These are the cornerstone drugs in the treatment of TB. MDR-TB's resistance to these drugs necessitates the use of second-line medications and a longer, more complex treatment regimen.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Isoniazid, rifampicin, and fluoroquinolone</strong>: While resistance to fluoroquinolones can occur, it characterizes pre-extensively drug-resistant (pre-XDR) TB or extensively drug-resistant (XDR) TB, not just MDR-TB.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Fluoroquinolones</strong>: Fluoroquinolone resistance typically occurs in more advanced drug-resistant TB cases like pre-XDR and XDR-TB.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Isoniazid, rifampicin, and kanamycin</strong>: This option refers to XDR-TB, which includes resistance to at least isoniazid, rifampicin, a fluoroquinolone, and a second-line injectable drug such as kanamycin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Note </strong>– Old definition of XDR - H and R resistance plus at least one fluoroquinolone resistance plus at least one second line injectable drug resistance like aminoglycosides (amikacin, kanamycin and capreomycin).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Multidrug-resistant tuberculosis (MDR-TB) is defined by its resistance to at least isoniazid and rifampicin, the two most important first-line anti-TB drugs.</span></p>",
      "correct_choice_id": 45444,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24728,
      "choices": [
        {
          "id": 98873,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Amyloid light chain (AL)</span></span></span></p>"
        },
        {
          "id": 98874,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Amyloid associated protein (AA)</span></span></span></p>"
        },
        {
          "id": 98875,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Amyloid &beta;2 microglobulin (A&beta;2M)</span></span></span></p>"
        },
        {
          "id": 98876,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Amyloid transthyretin (ATTR)</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which type of amyloidosis is more likely to develop in a patient undergoing long-term hemodialysis due to renal failure?</span></span> <span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">INICET MAY 2023)</span></span></p>",
      "unique_key": "Q1458022",
      "question_audio": null,
      "question_video": null,
      "map_id": 13057239,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Amyloid&nbsp;&beta;2 microglobulin (A&beta;2M)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Hemodialysis-associated amyloidosis (HAA)&nbsp;</span></strong><span style=\"font-size:12.0pt\">is a condition that occurs in patients who have been undergoing long-term hemodialysis, typically for chronic renal failure. The culprit protein in this form of amyloidosis is <strong>&beta;2-microglobulin (A&beta;2M)</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">&beta;2-microglobulin</span></strong><span style=\"font-size:12.0pt\"> is a component of MHC class I molecules and is normally filtered out by the kidneys. In patients with renal failure, and especially those on long-term dialysis, &beta;2-microglobulin accumulates because it is not efficiently removed by the dialysis membrane. Over time, this accumulation can lead to the deposition of amyloid fibrils composed of A&beta;2M in various tissues, particularly around joints, leading to conditions like carpal tunnel syndrome and other forms of osteoarticular amyloidosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Amyloid light chain (AL)</span></strong><span style=\"font-size:12.0pt\">: This type of amyloidosis is associated with plasma cell dyscrasias, such as multiple myeloma, where abnormal light chains are produced and deposit as amyloid.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Amyloid associated protein (AA)</span></strong><span style=\"font-size:12.0pt\">: AA amyloidosis is secondary to chronic inflammatory conditions like tuberculosis, rheumatoid arthritis, or chronic infections, where Serum Amyloid A (SAA) is overproduced and deposits as amyloid.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Amyloid transthyretin (ATTR)</span></strong><span style=\"font-size:12.0pt\">: ATTR amyloidosis involves transthyretin, a protein produced in the liver, which can form amyloid deposits either due to genetic mutations (familial amyloid polyneuropathies) or in wild-type form, primarily affecting the heart.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>&nbsp;</strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Long-term hemodialysis patients with renal failure may experience the development of amyloidosis due to the accumulation of A&beta;2-microglobulin.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Additional Information</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A. Generalized/Systemic Amyloidosis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/03/screenshot-2024-09-03-171322.png\" style=\"height:325px; width:1000px\" /></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">B. Localised Amyloidosis </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/03/screenshot-2024-09-03-171541.png\" style=\"height:451px; width:1000px\" /></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">C. Hereditary Amyloidosis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/03/screenshot-2024-09-03-171641.png\" style=\"height:237px; width:1000px\" /></p>",
      "correct_choice_id": 98875,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14400,
      "choices": [
        {
          "id": 57561,
          "text": "<p><span style=\"font-size:12.0pt;\">BIRADS 1 or 2</span></p>"
        },
        {
          "id": 57562,
          "text": "<p><span style=\"font-size:12.0pt;\">BIRADS 2 or 4</span></p>"
        },
        {
          "id": 57563,
          "text": "<p><span style=\"font-size:12.0pt;\">BIRADS 2, 3, or 4</span></p>"
        },
        {
          "id": 57564,
          "text": "<p><span style=\"font-size:12.0pt;\">BIRADS 2</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the appropriate BIRADS category for a 23-year-old woman with a breast lump, no skin changes, and no indurations, whose histology shows a fibroadenoma appearance? (INICET NOV 2022)</span></p>",
      "unique_key": "Q4450552",
      "question_audio": null,
      "question_video": null,
      "map_id": 13057240,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) BIRADS 2</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">BIRADS 2 is used for benign findings. Given that the histology shows a fibroadenoma appearance, which is a well-recognized benign breast condition, BIRADS 2 is the most suitable category for this scenario.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. BIRADS 1 or 2</strong>: BIRADS 1 is assigned to a category when there is no suspicion of malignancy, and BIRADS 2 is used when there is a benign finding. In this case, since the histology shows a fibroadenoma appearance, which is a benign breast condition, BIRADS 2 is the most appropriate category.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. BIRADS 2 or 4</strong>: BIRADS 4 is used when there is a suspicious abnormality that may or may not be cancerous. Since the histology in this case indicates a fibroadenoma appearance, which is benign, BIRADS 4 would not be appropriate.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>BIRADS 2, 3, or 4</strong>: BIRADS 3 is assigned when there is a probably benign finding that requires short-term follow-up. In this case, since the histology indicates a fibroadenoma appearance (a benign finding), BIRADS 3 and BIRADS 4 would not be applicable.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In the case of a 23-year-old woman with a breast lump, no skin changes, and no indurations, whose histology shows a fibroadenoma appearance, the appropriate BIRADS category is BIRADS 2.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Fibroadenoma is a benign tumor that poses a low risk of malignancy. The Breast Imaging Reporting and Data System (BIRADS) categories are used to assess the likelihood of malignancy of breast lesions seen on mammograms, ultrasounds, or MRI. Grades 1 and 2 have a very low probability of being malignant, while grade 3 has a slightly higher probability of malignancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Grades 4 and 5 are considered suspicious and warrant further investigation as they have a higher probability of malignancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/17/screenshot-2023-11-17-171804.jpg\" alt=\"\" width=\"1000\" height=\"494\"></span></p>",
      "correct_choice_id": 57564,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59577,
      "choices": [
        {
          "id": 237621,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">ASA I</span></span></span></p>"
        },
        {
          "id": 237622,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">ASA II</span></span></span></p>"
        },
        {
          "id": 237623,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">ASA III</span></span></span></p>"
        },
        {
          "id": 237624,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ASA IV</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 65-year-old man with a history of poorly controlled type 2 diabetes, chronic kidney disease stage 3, and stable angina is scheduled for elective surgery. He experiences occasional chest pain that is relieved with rest and medications. His daily activities are somewhat limited by his health conditions, but he is not incapacitated. Which of the following ASA Physical Status Classifications corresponds to this patient?</span></span></span></p>",
      "unique_key": "Q7966928",
      "question_audio": null,
      "question_video": null,
      "map_id": 13057241,
      "difficulty_level": "intermediate",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Answer:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>C) ASA III</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The American Society of Anesthesiologists (ASA) Physical Status Classification System is used to assess a patient&#39;s preoperative health status and the associated risk during anesthesia. The system ranges from ASA I to ASA VI, each level describing the severity of the patient&#39;s systemic illness and its impact on their overall health and surgical risk.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">ASA I:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> A normal healthy patient with no systemic disease and no limitations in their daily activities. Examples include a fit, non-smoking patient with no or minimal alcohol use.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">ASA II:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> A patient with mild systemic disease that is well controlled and does not significantly limit daily activities. Examples include controlled hypertension, mild diabetes without end-organ damage, mild obesity, or a history of smoking.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">ASA III:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> A patient with severe systemic disease that is not incapacitating. This category includes individuals whose health conditions are serious and impact their daily life but do not pose a constant threat to life. Examples include poorly controlled diabetes, stable angina, chronic kidney disease, or morbid obesity. The patient described here fits this category because his comorbidities are severe but managed well enough to avoid constant life-threatening status.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">ASA IV:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> A patient with severe systemic disease that poses a constant threat to life. Conditions in this category include unstable angina, advanced heart failure, or end-stage renal disease requiring dialysis. Patients in this group are often severely limited in their daily activities due to their illness.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">ASA V:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> A moribund patient who is not expected to survive without the operation. These patients have conditions such as a ruptured aortic aneurysm, massive trauma, or severe intracranial hemorrhage that necessitate surgery for any chance of survival.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">ASA VI:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> A declared brain-dead patient whose organs are being removed for donor purposes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A) ASA I:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This option is incorrect because it refers to healthy individuals without systemic disease, which does not match the patient&#39;s complex medical history.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B) ASA II:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> ASA II is reserved for patients with mild systemic disease that does not significantly impact daily activities or pose a substantial risk during surgery. The patient&rsquo;s conditions, including poorly controlled diabetes and stable angina, are more severe than what is described by ASA II.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D) ASA IV:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> ASA IV describes patients with severe systemic disease that poses a constant threat to life, such as unstable angina or advanced heart failure. While the patient&#39;s conditions are serious, they are not immediately life-threatening, placing him in ASA III rather than IV.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ASA grade III is used to classify patients with severe systemic disease that significantly impacts daily functioning but is not incapacitating or an immediate threat to life. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Understanding the distinctions between ASA grades helps in assessing perioperative risk and planning for anesthesia management.</span></span></p>",
      "correct_choice_id": 237623,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10141,
      "choices": [
        {
          "id": 40530,
          "text": "<p><span style=\"font-size:12.0pt;\">No malnutrition - Assure the mother</span></p>"
        },
        {
          "id": 40531,
          "text": "<p><span style=\"font-size:12.0pt;\">Mild malnutrition - home treatment</span></p>"
        },
        {
          "id": 40532,
          "text": "<p><span style=\"font-size:12.0pt;\">Severe malnutrition - refer to nutrition rehabilitation center</span></p>"
        },
        {
          "id": 40533,
          "text": "<p><span style=\"font-size:12.0pt;\">Moderate malnutrition - teach the mother on how to feed</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 16-month-old boy is found to weigh 8kg. A WHO growth chart (weight-for-height) is provided below. Plot the growth chart for this child. What is the most appropriate advice based on the plotted graph? (NEET PG 2021)</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/0009.png\" width=\"975\" height=\"583\"></p><p>&nbsp;</p>",
      "unique_key": "Q1676557",
      "question_audio": null,
      "question_video": null,
      "map_id": 13057242,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Moderate malnutrition - teach the mother on how to feed</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The WHO growth chart (weight-for-height) shows that the weight of 8 kg for a 16-month-old boy falls between -2 standard deviations (SD) and -3 SD, indicating moderate malnutrition. This suggests that the child is not receiving adequate nutrition and is at risk for growth and developmental delays.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In such cases, it is important to educate the mother on proper feeding practices to ensure the child receives a balanced diet with adequate nutrients. This can involve guidance on meal frequency, food variety, and portion sizes to improve the child's nutritional status.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. No malnutrition - Assure the mother:&nbsp;</strong>This option is incorrect because the child’s weight for height falls between -2SD and -3SD on the growth chart, indicating moderate malnutrition rather than no malnutrition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Mild malnutrition - home treatment:&nbsp;</strong>This option is incorrect as mild malnutrition is indicated when the weight-for-height is between -1SD and -2SD. The child’s weight falls between -2SD and -3SD, indicating moderate malnutrition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Severe malnutrition - refer to nutrition rehabilitation center:&nbsp;</strong>This option is incorrect because severe malnutrition is diagnosed when the weight-for-height is less than -3SD. The child’s weight does not fall into this category.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Moderate malnutrition in children is indicated by a weight-for-height between -2SD and -3SD on the WHO growth chart, necessitating education on proper feeding practices.</span></p>",
      "correct_choice_id": 40533,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 32732,
      "choices": [
        {
          "id": 130778,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Acrocentric</span></span></span></p>"
        },
        {
          "id": 130779,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">﻿﻿﻿Metacentric</span></span></span></p>"
        },
        {
          "id": 130780,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">﻿﻿﻿Submetacentric</span></span></span></p>"
        },
        {
          "id": 130781,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">﻿﻿﻿Telocentric</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify the type of marked chromosome in the given karyotype?&nbsp;</span></span>(INICET MAY 2021)</p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/09/15.jpg\" style=\"height:225px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q5590199",
      "question_audio": null,
      "question_video": null,
      "map_id": 13057243,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) Acrocentric </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The marked chromosome is chromosome 13 and the type is acrocentric.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Each chromatid has a long arm &ldquo;q&rdquo; and a short arm &ldquo;p&rdquo; </span></strong><span style=\"font-size:12.0pt\">which are separated by a centromere. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Metacentric:</span></strong><span style=\"font-size:12.0pt\"> Metacentric chromosomes have the centromere located in the center, creating arms of equal length. Examples include chromosomes 1 and 3.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Submetacentric:</span></strong><span style=\"font-size:12.0pt\"> Submetacentric chromosomes have the centromere slightly off-center, creating one long arm and one short arm. Most human autosomes and the X chromosome are submetacentric.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Telocentric:</span></strong><span style=\"font-size:12.0pt\"> Telocentric chromosomes have the centromere at the very end of the chromosome, creating only one arm. This type is not present in humans.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Chromosomes are classified based on the position of the centromere as follows:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/04/screenshot-2024-06-04-125703.jpg\" style=\"height:436px; width:1000px\" /></p>",
      "correct_choice_id": 130778,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13025,
      "choices": [
        {
          "id": 52062,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Flying missiles</span></span></span></p>"
        },
        {
          "id": 52063,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Blast of air</span></span></span></p>"
        },
        {
          "id": 52064,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explosion burns</span></span></span></p>"
        },
        {
          "id": 52065,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Furniture abrasions</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A man who was involved in a bomb blast at a railway station was brought to the hospital with multiple small puncture wounds to the left side of the chest and multiple small abrasions all over the body. Which of the following mechanisms is responsible for these injuries? (</span></span>INICET Nov 2021)</p>",
      "unique_key": "Q1045987",
      "question_audio": null,
      "question_video": null,
      "map_id": 13057244,
      "difficulty_level": "beginner",
      "subjects_id": [
        10
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Flying missiles</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The case scenarios define multiple abrasions and puncture wounds suggestive of blast injuries due to flying missiles.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">T.K. Marshall&#39;s (Marshall&#39;s triad of bomb injuries) :</span></strong><strong> </strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"list-style-type:none\">\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Abrasions</span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Bruises/contusions</span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Puncture lacerations</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Blast of air:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Primarily causes primary blast injuries, which affect air-filled organs and do not typically result in puncture wounds.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Explosion burns:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Involve thermal injuries and burns rather than puncture wounds and abrasions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Furniture abrasions:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Would result from the victim being thrown into furniture or debris, causing blunt force injuries rather than puncture wounds.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Classification of Blast injuries:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Injuries from explosions are traditionally classified into: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ol>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Primary blast injuries</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: injuries due to solely to the blast wave </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Secondary blast or explosive injury</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: primarily ballistic trauma resulting from fragmentation wounds from the explosive device or the environment </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tertiary blast or explosive injury:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">result of displacement of the victim or environmental structures, is largely blunt traumatic injuries</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Quaternary explosive injuries:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">burns, toxins, and radiologic contamination </span></span></span></li>\r\n</ol>",
      "correct_choice_id": 52062,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5873,
      "choices": [
        {
          "id": 23462,
          "text": "<p><span style=\"font-size:12pt;\">Danazol</span></p>"
        },
        {
          "id": 23463,
          "text": "<p><span style=\"font-size:12pt;\">CuT200</span></p>"
        },
        {
          "id": 23464,
          "text": "<p><span style=\"font-size:12pt;\">RU486</span></p>"
        },
        {
          "id": 23465,
          "text": "<p><span style=\"font-size:12pt;\">Combined high dose estrogen-progestin pills</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following are contraceptive methods used post-coitus except?&nbsp;</span>(NEET PG 2020)</p>",
      "unique_key": "Q3052466",
      "question_audio": null,
      "question_video": null,
      "map_id": 13057245,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Danazol</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Post coitus contraception means emergency contraception</span></li><li><span style=\"font-size:12pt;\">Danazol is an androgen similar to testosterone and is used in endometriosis and fibrocystic breast disease</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B CuT200</strong>: CUT200 is an intrauterine contraceptive device which can be used in emergency contraception (up to 120 h/ 5 days post coitus)</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. RU486</strong>: RU486 is Mifepristone. This is an anti-progesterone and can be used for emergency contraception)</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Combined high dose estrogen-progestin pills:</strong> Combined high dose OCPs – used as Yuzpe’s regime, is a method of post-coital/ emergency contraception&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The following can be used as emergency contraceptives:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/15/11.jpg\" alt=\"\" width=\"1000\" height=\"384\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 630, DC Dutta’s Textbook of Gynecology, 6<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23462,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9996,
      "choices": [
        {
          "id": 39950,
          "text": "<p><span style=\"font-size:12.0pt;\">NK cells</span></p>"
        },
        {
          "id": 39951,
          "text": "<p><span style=\"font-size:12.0pt;\">All nucleated cells</span></p>"
        },
        {
          "id": 39952,
          "text": "<p><span style=\"font-size:12.0pt;\">B cells, dendritic cells, mononuclear phagocytes</span></p>"
        },
        {
          "id": 39953,
          "text": "<p><span style=\"font-size:12.0pt;\">Platelets</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Among the following, which cells have MHC class II? (AIIMS NOV 2017)</span></p>",
      "unique_key": "Q6058955",
      "question_audio": null,
      "question_video": null,
      "map_id": 13057246,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) B cells, dendritic cells, mononuclear phagocytes</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Class II</strong> major histocompatibility complex (MHC) molecules are mainly expressed on macrophages, B lymphocytes, and dendritic cells. These cells present ingested antigens to T-cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Class I</strong> major histocompatibility complex are expressed on all nucleated cells</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Class III</strong> major histocompatibility complex are some components of the complement system (C2 and C4) coded on HLA complex but are not associated with HLA expression and are not used in antigen identification.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/82.jpg\" alt=\"\" width=\"700\" height=\"501\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">MHC antigens present on the cell surface help the macrophage in its function of bacterial antigen recognition i.e., they help to identify self from foreign, and accordingly present the foreign antigen to T cells (CD4+ or CD8+) or to B cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">MHC I are located on a portion of <strong>chromosome 6</strong>p of all nucleated cells of the body and platelets. These genes occupy four regions or loci—A, B, C and D, on the short (p) arm of chromosome 6 and exhibit marked variation in allelic genes at each locus. Therefore, the product of HLA antigens is highly polymorphic.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The genes encoding HLA molecules are clustered on the short arm of chromosome 6.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Role of MHC/ HLA typing include:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Organ Transplantation</span></li><li><span style=\"font-size:12.0pt;\">Regulation of immune system</span></li><li><span style=\"font-size:12.0pt;\">Association of diseases with HLA. An increasing number of diseases have been found to have association with some specific histocompatibility antigens. Ex:</span></li><li><span style=\"font-size:12.0pt;\">Inflammatory disorders e.g., ankylosing spondylitis</span></li><li><span style=\"font-size:12.0pt;\">Autoimmune disorders e.g., rheumatoid arthritis, insulin dependent diabetes mellitus.</span></li><li><span style=\"font-size:12.0pt;\">Inherited disorders of metabolism e.g., idiopathic haemochromatosis.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;A. NK cells</strong>: While natural killer (NK) cells play a role in immune responses, they do not express MHC class II molecules.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;B. All nucleated cells</strong>: This describes MHC Class I expression, not MHC Class II.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D. Platelets</strong>: Although platelets are derived from nucleated cells, they do not express MHC Class II molecules.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>MHC Class II molecules&nbsp;</strong>are primarily expressed on antigen presenting cells&nbsp;(<strong>B cells, dendritic cells, and mononuclear phagocytes)</strong>, which are essential for antigen presentation to T-helper cells.</span></p>",
      "correct_choice_id": 39952,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44833,
      "choices": [
        {
          "id": 178979,
          "text": "<p><span style=\"font-size:12pt;\">It should not be given with pyrazinamide</span></p>"
        },
        {
          "id": 178980,
          "text": "<p><span style=\"font-size:12pt;\">It should be taken empty stomach</span></p>"
        },
        {
          "id": 178981,
          "text": "<p><span style=\"font-size:12pt;\">It is given as a loading dose</span></p>"
        },
        {
          "id": 178982,
          "text": "<p><span style=\"font-size:12pt;\">It requires therapeutic drug monitoring</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A 50-year-old male patient with a history of chronic pulmonary aspergillosis is being treated with voriconazole. He has been on the medication for two weeks and comes to the clinic for a follow-up. During the visit, he asks about the specific guidelines and considerations for taking voriconazole to ensure its effectiveness and safety. Which of the following statements is true about voriconazole? (</span>INICET May 2024)</p>",
      "unique_key": "Q9467334",
      "question_audio": null,
      "question_video": null,
      "map_id": 13057340,
      "difficulty_level": "difficult",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) It is given as a loading dose</strong></span><br>&nbsp;</p><p><span style=\"font-size:12pt;\">Voriconazole requires a loading dose to rapidly achieve therapeutic levels in the body. This is a crucial aspect of its administration, especially in acute settings where rapid antifungal activity is needed.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>A.</strong>&nbsp;<strong>It should not be given with pyrazinamide</strong>: There is no significant interaction between voriconazole and pyrazinamide. Voriconazole does interact with many other medications due to its effect on cytochrome P450 enzymes, but pyrazinamide is not one of the primary concerns.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. It should be taken empty stomach</strong>: Voriconazole can be taken either with or without food, but it is generally recommended to take it one hour before or one hour after a meal to ensure optimal absorption. While this is important, it is not the most critical consideration compared to therapeutic drug monitoring.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>D.</strong>&nbsp;<strong>It requires therapeutic drug monitoring</strong>: While therapeutic drug monitoring can be important for voriconazole, especially in certain patient populations, it is not as universally mandated or emphasized as the initial loading dose regimen in standard treatment protocols.</span></p><p style=\"margin-left:48px;\">&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p style=\"margin-left:48px;\">&nbsp;</p><p><span style=\"font-size:12pt;\">In summary, the statement that voriconazole \"is given as a loading dose\" is the most universally applicable and critical aspect of its administration, especially for ensuring rapid therapeutic levels in treating fungal infections.</span></p>",
      "correct_choice_id": 178981,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24778,
      "choices": [
        {
          "id": 99073,
          "text": "<p><span style=\"font-size:11.0pt;\">Vascular disease with bronchodilator reversibility</span></p>"
        },
        {
          "id": 99074,
          "text": "<p><span style=\"font-size:11.0pt;\">Restrictive lung disease with bronchodilator reversibility</span></p>"
        },
        {
          "id": 99075,
          "text": "<p><span style=\"font-size:11.0pt;\">Restrictive lung disease without bronchodilator reversibility</span></p>"
        },
        {
          "id": 99076,
          "text": "<p><span style=\"font-size:11.0pt;\">Obstructive disease with bronchodilator reversibility</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A chronic cigarette smoker now joined a construction company. His pulmonary function test results are given below.(INICET MAY 2023)</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Initial lung volumes were: FEV1 - 0.9L, FVC - 1.9L, FEV1/FVC - 0.4</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">After bronchodilation: FEV1 - 1.9L, FVC - 3.9L, FEV1/FVC - 0.4</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">What is the most likely diagnosis for this patient?</span></p>",
      "unique_key": "Q7107803",
      "question_audio": null,
      "question_video": null,
      "map_id": 13057341,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D)&nbsp;Obstructive disease with bronchodilator reversibility</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The pulmonary function test results show a reduced FEV1/FVC ratio, consistent with obstructive lung disease. Significant improvement in FEV1 post-bronchodilation indicates reversibility (FEV1 - anything &gt;200ml is significant), suggesting conditions like asthma or COPD with reversible obstruction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p><br><span style=\"font-size:12pt;\"><strong>Option A. Vascular disease with bronchodilator reversibility</strong>: Pulmonary function tests do not suggest vascular disease.</span></p><p><br><span style=\"font-size:12pt;\"><strong>Option B. Restrictive lung disease with bronchodilator reversibility:</strong> Restrictive diseases show reduced volumes but normal or increased FEV1/FVC ratio.</span></p><p><br><span style=\"font-size:12pt;\"><strong>Option C. Restrictive lung disease without bronchodilator reversibility</strong>: Not applicable as the patient shows obstructive pattern with reversibility.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Obstructive lung diseases, such as asthma or COPD, may show bronchodilator reversibility.</span></p>",
      "correct_choice_id": 99076,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14804,
      "choices": [
        {
          "id": 59177,
          "text": "<p><span style=\"font-size:12.0pt;\">a, b, c are correct</span></p>"
        },
        {
          "id": 59178,
          "text": "<p><span style=\"font-size:12.0pt;\">a and c are correct</span></p>"
        },
        {
          "id": 59179,
          "text": "<p><span style=\"font-size:12.0pt;\">b and d are correct</span></p>"
        },
        {
          "id": 59180,
          "text": "<p><span style=\"font-size:12.0pt;\">a, b, c, d are correct</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Evaluate the following statements with respect to intertrochanteric fracture: (</span>AIIMS Nov 2019)</p><p style=\"text-align:justify;\">&nbsp;</p><ol style=\"list-style-type:lower-alpha;\"><li><span style=\"font-size:12.0pt;\">More common in males than females.</span></li><li><span style=\"font-size:12.0pt;\">1 year mortality rate is 20-30%.</span></li><li><span style=\"font-size:12.0pt;\">It is more commonly associated with nonunion than fracture neck of femur.</span></li><li><span style=\"font-size:12.0pt;\">1 year mortality can be reduced by operating within 48 hours.</span></li></ol>",
      "unique_key": "Q2197129",
      "question_audio": null,
      "question_video": null,
      "map_id": 13057342,
      "difficulty_level": "intermediate",
      "subjects_id": [
        15
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) b and d are correct.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>INTERTROCHANTERIC FRACTURE FEMUR</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Intertrochanteric fractures are extracapsular fractures of the proximal femur that occur between the greater and lesser trochanter.</span></li><li><span style=\"font-size:12.0pt;\">This metaphyseal region has a more abundant blood supply, contributing to a higher union rate and less osteonecrosis compared to femoral neck fractures.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Etiology:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">These fractures occur both in the elderly and the young, but they are more common in the elderly population with osteoporosis due to a low energy mechanism.&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">The female to male ration is between 2:1 and 8:1.</span></li><li><span style=\"font-size:12.0pt;\">In the younger population, these fractures typically result from a high-energy mechanism.</span></li></ul></li><li><span style=\"font-size:12.0pt;\">These patients present with a short and externally rotated limb.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Treatment:</strong></span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/17/screenshot-2024-01-17-155254_OXXasFn.jpg\" alt=\"\" width=\"700\" height=\"306\"></p><p>&nbsp;</p><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\"><strong>Treatment of choice:&nbsp;</strong>Dynamic Hip Screw (Undisplaced fracture).</span></li><li><span style=\"font-size:12.0pt;\"><strong>Displaced fracture:&nbsp;</strong>Proximal femoral nail (Cephalomedullary nail).</span></li><li><span style=\"font-size:12.0pt;\">Latest literature claims better results with Proximal Femoral Nail (PFN).</span></li><li><span style=\"font-size:12.0pt;\">Most common complication is malunion.</span></li><li><span style=\"font-size:12.0pt;\">1 year mortality rate is 20-30%.</span></li><li><span style=\"font-size:12.0pt;\">1 year mortality can be reduced by operating within 48 hours.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>INTERTROCHANTERIC FRACTURE VS NECK OF FEMUR FRACTURE</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/17/screenshot-2024-01-17-155523.jpg\" alt=\"\" width=\"1000\" height=\"688\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Intertrochanteric fracture is more common in females than males.</span></li><li><span style=\"font-size:12.0pt;\">Most common complication is malunion.</span></li><li><span style=\"font-size:12.0pt;\">1 year mortality rate is 20-30%.</span></li><li><span style=\"font-size:12.0pt;\">1 year mortality can be reduced by operating within 48 hours.</span></li></ul>",
      "correct_choice_id": 59179,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15611,
      "choices": [
        {
          "id": 62404,
          "text": "<p><span style=\"font-size:12.0pt;\">EPL and EPB</span></p>"
        },
        {
          "id": 62405,
          "text": "<p><span style=\"font-size:12.0pt;\">APL and EPB</span></p>"
        },
        {
          "id": 62406,
          "text": "<p><span style=\"font-size:12.0pt;\">APL and APB</span></p>"
        },
        {
          "id": 62407,
          "text": "<p><span style=\"font-size:12.0pt;\">APL and EPL</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which tendons are involved in the test shown below?(NEET PG 2020)</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/16/untitled-1311.jpg\" alt=\"\" width=\"300\" height=\"328\"></p>",
      "unique_key": "Q1507424",
      "question_audio": null,
      "question_video": null,
      "map_id": 13057343,
      "difficulty_level": "beginner",
      "subjects_id": [
        15
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) APL and EPB</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Finkelstein test has been shown which helps to diagnose de Quervain’s tenosynovitis (Inflammation of Abductor Pollicis Longus and Extensor Pollicis brevis).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>DE QUERVAIN’S TENOSYNOVITIS</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The abductor pollicis longus and extensor pollicis brevis tendons may become inflamed beneath the retinacular pulley at the radial styloid within the first extensor compartment.</span></li><li><span style=\"font-size:12.0pt;\">Finkelstein’s test is pathognomonic.</span></li><li><span style=\"font-size:12.0pt;\">The examiner places patients’ thumb across the palm in full flexion, and then holding the patient’s hand firmly, turns the wrist sharply into adduction.</span></li><li><span style=\"font-size:12.0pt;\">In positive test, this is acutely painful; repeating the movement with the thumb left free is relatively painless.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/16/untitled-1312.jpg\" alt=\"\" width=\"400\" height=\"317\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Differential diagnosis includes scaphoid non-union, arthritis at the base of thumb and intersection syndrome.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Treatment includes NSAIDs with splint.</strong> If it fails, then steroid injection into tendon sheath and if not relieved then treatment consists of splitting the thickened tendon sheath.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Abductor pollicis longus and extensor pollicis brevis tendons are inflamed in the condition called De Quervain Tenosynovitis.</span></li><li><span style=\"font-size:12.0pt;\">The diagnostic special test for the condition is called Finkelstein Test as shown in the image in the question.&nbsp;</span></li></ul>",
      "correct_choice_id": 62405,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased",
        "InvestigationBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21454,
      "choices": [
        {
          "id": 85780,
          "text": "<p><span style=\"font-size:12.0pt;\">AML t (8;21)</span></p>"
        },
        {
          "id": 85781,
          "text": "<p><span style=\"font-size:12.0pt;\">AML t (15;17)</span></p>"
        },
        {
          "id": 85782,
          "text": "<p><span style=\"font-size:12.0pt;\">AML t (16;16)</span></p>"
        },
        {
          "id": 85783,
          "text": "<p><span style=\"font-size:12.0pt;\">AML with NMP</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient with reduced hemoglobin and gum bleeding presented to you. He has thrombocytopenia (platelet count 25,000/µl) elevated PT, and aPTT. Which of the following can the probable cause of his finding? (NEETPG 2023)</span></p>",
      "unique_key": "Q7530855",
      "question_audio": null,
      "question_video": null,
      "map_id": 13057344,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) AML t (15;17)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The clinical presentation of reduced hemoglobin, gum bleeding, thrombocytopenia, and elevated PT and aPTT is suggestive of disseminated intravascular coagulation (DIC). Acute promyelocytic leukemia (APL), which is associated with the t(15;17) translocation, is a subtype of acute myeloid leukemia (AML) that commonly presents with DIC.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Acute Promyelocytic Leukemia (APL):</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Genetics:</strong> APL is characterized by the t(15;17) translocation, which results in the PML-RARA fusion gene. This translocation disrupts the retinoic acid receptor alpha (RARA) gene, leading to a block in myeloid differentiation at the promyelocyte stage.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Clinical Features:</strong> Patients often present with symptoms of bleeding (e.g., gum bleeding, bruising) due to DIC, which is a common complication of APL.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Laboratory Findings:</strong> Thrombocytopenia, elevated PT, and aPTT are consistent with DIC. The peripheral smear may show promyelocytes with Auer rods.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Management:</strong> APL is treated with all-trans retinoic acid (ATRA), which induces differentiation of the malignant promyelocytes.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. AML t(8;21):&nbsp;</strong>Associated with AML with maturation, typically presenting with myeloblasts and not commonly associated with DIC.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. AML t(16;16):&nbsp;</strong>Associated with AML with abnormal eosinophils, also not commonly associated with DIC.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. AML with NPM1:&nbsp;</strong>NPM1 mutations are common in AML but do not specifically correlate with DIC or the presentation described.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Acute promyelocytic leukemia (APL) associated with t(15;17) translocation commonly presents with DIC, characterized by thrombocytopenia and elevated coagulation times (PT and aPTT). DIC is due to release of procoagulant substances from the abnormal promyelocytes. Immediate identification and treatment with ATRA are crucial to manage this condition effectively.</span></p>",
      "correct_choice_id": 85781,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11116,
      "choices": [
        {
          "id": 44430,
          "text": "<p><span style=\"font-size:18px;\">Perceived control</span></p>"
        },
        {
          "id": 44431,
          "text": "<p><span style=\"font-size:18px;\">Behavioral modification</span></p>"
        },
        {
          "id": 44432,
          "text": "<p><span style=\"font-size:18px;\">Health motivation</span></p>"
        },
        {
          "id": 44433,
          "text": "<p><span style=\"font-size:18px;\">Self-efficacy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>In the context of the health belief model, a medical student is reviewing its different components. One of the boxes, labeled \"C\", is described as the individual's willingness to act on their beliefs regarding health threats and the benefits of taking preventive action. Which of the following best represents box C? </strong><i><strong>[INICET MAY 2022]</strong></i></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/23/ip24.jpg\" alt=\"\" width=\"700\" height=\"303\"></strong></span></p>",
      "unique_key": "Q3943742",
      "question_audio": null,
      "question_video": null,
      "map_id": 13148438,
      "difficulty_level": "difficult",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (c) Health motivation</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Box C stands for health motivation.</span></li><li><span style=\"font-size:18px;\">This represents the individual's readiness and willingness to engage in health-promoting behaviors.</span></li><li><span style=\"font-size:18px;\">This motivation influences how individuals perceive their susceptibility and severity of health issues, as well as the benefits and barriers to taking action.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/27/picture2666.jpg\" alt=\"\" width=\"900\" height=\"504\"></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The health belief model was proposed from the idea that a person's health behaviour changes in accordance with certain beliefs.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">It can be categorized as follows:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Individual perceptions.</span></li><li><span style=\"font-size:18px;\">Variable factors that modify beliefs.</span></li><li><span style=\"font-size:18px;\">Action.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Individual perceptions:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Perceived susceptibility refers to a person's own beliefs about the probability of developing a disease. If the perceived susceptibility is high, an individual is more likely to engage in health-promoting behaviour to reduce the chances of contracting the illness.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Perceived severity is an individual's assessment of the severity of a particular health problem. If the disease is perceived to have a high severity, then the person is more likely to adopt a healthier lifestyle. Perceived threat comprises perceived susceptibility and severity. People with a higher perceived threat tend to take on health-promoting activities.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Action:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Perceived benefits refer to a person's subjective judgment on how a particular health habit is modifying his chances of developing a disease. If the person believes that a habit is likely to reduce his/her chances of susceptibility to a disease or lower the severity of a disease, he/she is more likely to follow that healthy habit.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Perceived barriers to action also influence if a person wants to follow healthy behaviour. The benefits of a particular health habit must overweigh the barriers that a person must overcome to continue following that behaviour.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Cues to action may be internal or external. Internal cues include pain and clinical symptoms. External cues include awareness through media, physicians, and friends.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The health belief system is thought to be useful in analyzing health behaviour patterns and formulating disease prevention plans based on these beliefs. All internal and external factors, including demographic and psychological characteristics, aim at health motivation to attain the action phase of a health belief system.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A.</strong>&nbsp;<strong>Perceived control:</strong> Perceived control refers to a person's internal belief in the control they would have over things that are part of the past or the future or over a process, behavior, and outcome. Perceived control can influence all of the categories of the health belief system.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B.</strong>&nbsp;<strong>Behavioral modification: </strong>Behavioral modification is part of the action after assessing all of the above-mentioned concepts.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D.</strong>&nbsp;<strong>Self-efficacy: </strong>Self-efficacy can be defined as a person's capacity in achieving his health goals. A person's confidence in his/her ability to overcome limitations to attain his/her health goals was found to be a major factor in determining the outcome of his behavioral changes.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">In the health belief model, health motivation (Box C) represents an individual's willingness to act on their health beliefs regarding susceptibility, severity, benefits, and barriers to take preventive health actions.</span></li></ul>",
      "correct_choice_id": 44432,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}